| Symbol | UTHR |
|---|---|
| Name | UNITED THERAPEUTICS CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Pharmaceutical Preparations |
| Address | 1000 SPRING ST, SILVER SPRING, MD 20910 |
| Telephone | 3016089292 |
| Fax | — |
| — | |
| Website | https://www.unither.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001082554 |
| Description | United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The companys therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the companys sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension. Additional info from NASDAQ: |
2026-08-14 08:00
New Form SCHEDULE 13G/A - UNITED THERAPEUTICS Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001104659-26-096403 <b>Size:</b> 7 KB
Read more
2026-08-13 21:09
ROTHBLATT MARTINE A 🟡 adjusted position in 9.5K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $520.96 ($7.5M) Transaction Date: Aug 12, 2026 | Filing ID: 000119
Read more
2026-08-13 17:12
New Form SCHEDULE 13G/A - UNITED THERAPEUTICS Corp <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0000902219-26-000284 <b>Size:</b> 15 KB
Read more
2026-08-12 20:30
ROTHBLATT MARTINE A 🟡 adjusted position in 9.5K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $531.01 ($7.5M) Transaction Date: Aug 11, 2026 | Filing ID: 000118
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT06134076 | Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota | Na | Fermented Food | Not_Yet_Recruiting | 2027-09-01 | 2029-08-01 | ClinicalTrials.gov |
| NCT07166393 | Valproic AcId for Traumatic BRAin INjury Trial | Phase2 | Moderate Traumatic Brain Injury (TBI) | Not_Yet_Recruiting | 2027-05-01 | 2031-12-01 | ClinicalTrials.gov |
| NCT07743554 | Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractor… | Phase2 | MPNST (Malignant Peripheral Nerve Sheath Tumor) | Not_Yet_Recruiting | 2027-01-01 | 2032-01-01 | ClinicalTrials.gov |
| NCT03258658 | Safety and Feasibility Study of Autologous Engineered Urethral Constructs for t… | Phase1 | Urologic Diseases | Recruiting | 2027-01-01 | 2029-06-01 | ClinicalTrials.gov |
| NCT07665294 | Combination CurQD and Vedolizumab in Ulcerative Colitis | Phase4 | Ulcerative Colitis | Not_Yet_Recruiting | 2026-10-01 | 2027-06-23 | ClinicalTrials.gov |
| NCT07752563 | Pilot RCT of Computer-based Eye Movement Training | Na | Stroke | Not_Yet_Recruiting | 2026-10-01 | 2027-07-31 | ClinicalTrials.gov |
| NCT07715799 | Noninvasive Brain Stimulation Combined With Written Exposure Therapy for PTSD i… | Na | Post Traumatic Stress Disorder | Not_Yet_Recruiting | 2026-09-30 | 2030-09-01 | ClinicalTrials.gov |
| NCT07721259 | A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Bre… | Phase2 | Anatomic Stage I Breast Cancer AJCC v8 | Not_Yet_Recruiting | 2026-09-30 | 2030-07-16 | ClinicalTrials.gov |
| NCT07621094 | Intraosseous Antibiotics for Osseointegration | Na | Osseointegration Infection | Not_Yet_Recruiting | 2026-09-01 | 2031-12-01 | ClinicalTrials.gov |
| NCT07637240 | CRUISE System in Flight | — | Shock | Not_Yet_Recruiting | 2026-09-01 | 2027-09-01 | ClinicalTrials.gov |
| NCT07604701 | Examining the Efficacy of the Man Therapy Platform in Reducing Problematic Ange… | Na | Mild Traumatic Brain Injury (mTBI) | Not_Yet_Recruiting | 2026-09-01 | 2028-12-01 | ClinicalTrials.gov |
| NCT07691736 | Combining Fasting and Fibre Interventions to Optimise Their Gut Microbiome-medi… | Na | Fasting | Not_Yet_Recruiting | 2026-09-01 | 2027-03-01 | ClinicalTrials.gov |
| NCT07745569 | Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Th… | Phase2 | PTSD | Not_Yet_Recruiting | 2026-08-31 | 2030-06-30 | ClinicalTrials.gov |
| NCT07695688 | Safety Study of Microlyte DualGuard | Na | Wound Closure | Not_Yet_Recruiting | 2026-08-30 | 2027-08-01 | ClinicalTrials.gov |
| NCT07760467 | To Evaluate Safety, Tolerability, PK/PD & Food Effect of Single/Multiple Oral T… | Phase1 | Paroxysmal Nocturnal Hemoglobinuria, PNH | Not_Yet_Recruiting | 2026-08-26 | 2027-05-08 | ClinicalTrials.gov |
| NCT07659574 | Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus W… | Phase3 | Type 2 Diabetes | Not_Yet_Recruiting | 2026-08-10 | 2027-10-22 | ClinicalTrials.gov |
| NCT07251491 | Psilocybin to Treat Depression in Spinal Cord Injury | Phase1 | Spinal Cord Injury | Recruiting | 2026-08-06 | 2028-03-01 | ClinicalTrials.gov |
| NCT07694986 | Trial of Therapies With IT cDC1s Combined w/ IT Trastuzamab for Her+ or IT Nivo… | Phase2 | Breast Cancer | Recruiting | 2026-08-01 | 2030-08-01 | ClinicalTrials.gov |
| NCT07626931 | Abdominal Stimulation to Improve Cough After Spinal Cord Injury | Na | Spinal Cord Injuries (SCI) | Not_Yet_Recruiting | 2026-08-01 | 2028-06-01 | ClinicalTrials.gov |
| NCT07212998 | Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal… | Phase3 | Burn Injury | Not_Yet_Recruiting | 2026-08-01 | 2029-09-01 | ClinicalTrials.gov |
| NCT07724080 | Resistance Exercise, IL-7 and Immune Phenotypes in Prostate Cancer | Na | Prostate Cancer | Not_Yet_Recruiting | 2026-08-01 | 2028-09-01 | ClinicalTrials.gov |
| NCT07671872 | Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease | Na | Crohn's Disease, Active | Not_Yet_Recruiting | 2026-08-01 | 2030-08-01 | ClinicalTrials.gov |
| NCT07718243 | Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, M… | Phase1 | Melanoma (Skin Cancer) | Recruiting | 2026-08-01 | 2030-01-31 | ClinicalTrials.gov |
| NCT07755813 | Pirfenidone as Treatment of Chronic Pancreatitis | Phase2 | Chronic Pancreatitis | Not_Yet_Recruiting | 2026-08-01 | 2030-08-01 | ClinicalTrials.gov |
| NCT07756034 | Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platfo… | — | Cancer | Recruiting | 2026-08-01 | 2031-07-01 | ClinicalTrials.gov |
| NCT07532785 | Feasibility of Good Boost+ for Adults Awaiting Total Knee Replacement | Na | Osteoarthritis (Knee) | Recruiting | 2026-08-01 | 2028-02-01 | ClinicalTrials.gov |
| NCT07261241 | NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuxi… | Phase2 | Neuroblastoma | Not_Yet_Recruiting | 2026-07-31 | 2031-07-31 | ClinicalTrials.gov |
| NCT07648225 | UBT251 Injection Phase Ⅲ Study (Overweight or Obesity) | Phase3 | Obesity & Overweight | Not_Yet_Recruiting | 2026-07-31 | 2027-11-03 | ClinicalTrials.gov |
| NCT07653477 | Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes With Inade… | Phase3 | Type 2 Diabetes | Not_Yet_Recruiting | 2026-07-30 | 2028-02-29 | ClinicalTrials.gov |
| NCT07719257 | Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injec… | Phase1 | Complicated Urinary Tract Infections(cUTI) | Not_Yet_Recruiting | 2026-07-30 | 2026-12-30 | ClinicalTrials.gov |
| NCT07724132 | An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symp… | Phase3 | Alzheimer's Disease (AD) | Recruiting | 2026-07-24 | 2031-03-01 | ClinicalTrials.gov |
| NCT06162195 | The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Vers… | Na | Osteoarthritis, Hip | Recruiting | 2026-07-21 | 2036-12-31 | ClinicalTrials.gov |
| NCT07075042 | Comparing the Attentional Demands and Functional Outcomes in People With Transr… | Na | Amputation | Recruiting | 2026-07-01 | 2027-12-01 | ClinicalTrials.gov |
| NCT07288151 | MDMA-Assisted Massed Exposure Therapy for PTSD | Phase2 | Post Traumatic Stress Disorder | Recruiting | 2026-07-01 | 2030-01-01 | ClinicalTrials.gov |
| NCT07727629 | Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers | Phase1 | Gastro Esophageal Reflux Disorder | Not_Yet_Recruiting | 2026-07-01 | 2026-08-01 | ClinicalTrials.gov |
| NCT06690372 | Improving Heart Health in Individuals With SCI Using Home-Based Virtual Gaming | Na | Spinal Cord Injuries (SCI) | Recruiting | 2026-07-01 | 2027-08-31 | ClinicalTrials.gov |
| NCT07682948 | A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate… | Phase1 | Hypertension | Recruiting | 2026-07-01 | 2026-09-01 | ClinicalTrials.gov |
| NCT06702592 | Virtual Testis Cancer Lay Support and Survivorship Aim 2 | Na | Testicular Cancer | Not_Yet_Recruiting | 2026-07-01 | 2028-06-01 | ClinicalTrials.gov |
| NCT07376044 | RUSH Food is Medicine Veggie Rx - GusNIP Produce Prescription | Na | Food Insecurity | Not_Yet_Recruiting | 2026-06-30 | 2028-09-01 | ClinicalTrials.gov |
| NCT07447063 | The Impact of Dietary Salt on the Severity of Eczema | Phase4 | Eczema | Not_Yet_Recruiting | 2026-06-22 | 2028-05-05 | ClinicalTrials.gov |
| NCT07659821 | Harvesting Health: Advancing Nutrition and Wellness for Moms and Babies | Na | Pregnant Women With Singleton Pregnancies | Recruiting | 2026-06-22 | 2028-07-31 | ClinicalTrials.gov |
| NCT07634861 | Evaluating a Text-Prompt AI Assistant for Chest CT Scans (AI-REPORT Study) | Na | Thoracic Diseases | Recruiting | 2026-06-20 | 2027-02-15 | ClinicalTrials.gov |
| NCT07630233 | A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodyna… | Phase1 | Type 2 Diabetes Mellitus (T2DM) | Not_Yet_Recruiting | 2026-06-19 | 2026-10-25 | ClinicalTrials.gov |
| NCT07325760 | Effectiveness of a ReMIND Diet Intervention on Sarcopenia, Cognitive Frailty an… | Na | Sarcopenia | Not_Yet_Recruiting | 2026-06-15 | 2027-02-26 | ClinicalTrials.gov |
| NCT07071935 | A Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT A… | Phase2 | Amyotrophic Lateral Sclerosis (ALS) | Recruiting | 2026-06-11 | 2029-05-01 | ClinicalTrials.gov |
| NCT07691372 | Pharmacokinetics and Safety of Single-Dose Wafermine™ (Ketamine Sublingual Wafe… | Phase1 | Healthy Adult Participants | Not_Yet_Recruiting | 2026-06-09 | 2026-07-17 | ClinicalTrials.gov |
| NCT07762001 | Study to Evaluate the Safety and Tolerability of AD-NP1 in Healthy Human Adult … | Phase1 | Maximum Tolerated Dose | Active_Not_Recruiting | 2026-06-02 | 2028-05-01 | ClinicalTrials.gov |
| NCT07643974 | Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD | Early_Phase1 | Spinal Cord Injury | Not_Yet_Recruiting | 2026-06-01 | 2027-09-01 | ClinicalTrials.gov |
| NCT07660029 | BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Bas… | — | Rheumatoid Arthritis (RA) | Recruiting | 2026-06-01 | 2026-12-01 | ClinicalTrials.gov |
| NCT07417995 | A Study of Clinical and Immune Responses to Sequential Biologic Therapies in Ps… | — | Psoriasis Arthritis | Not_Yet_Recruiting | 2026-06-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT07460440 | SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Cl… | — | Lung Cancer | Not_Yet_Recruiting | 2026-06-01 | 2028-06-01 | ClinicalTrials.gov |
| NCT07628543 | Computer Vision-Based Recognition of Parathyroid Glands and Recurrent Laryngeal… | — | Thyroid Diseases | Not_Yet_Recruiting | 2026-06-01 | 2028-05-31 | ClinicalTrials.gov |
| NCT07224763 | Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patien… | Phase1 | ESRD (End-Stage Renal Disease) | Recruiting | 2026-06-01 | 2076-03-01 | ClinicalTrials.gov |
| NCT07612488 | A Study of CS231295 in Patients With Advanced Solid Tumors | Phase1 | Advance Solid Tumors | Not_Yet_Recruiting | 2026-06-01 | 2028-12-01 | ClinicalTrials.gov |
| NCT07688174 | The REFLECT Study- Flares in axSpA | — | Axial Spondyloarthritis (AxSpA) | Active_Not_Recruiting | 2026-06-01 | 2026-08-31 | ClinicalTrials.gov |
| NCT07377526 | TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Canc… | Phase1 | Pancreatic Cancer | Suspended | 2026-05-26 | 2030-03-01 | ClinicalTrials.gov |
| NCT07467707 | An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prev… | Phase3 | Chikungunya Virus | Recruiting | 2026-05-26 | 2030-05-01 | ClinicalTrials.gov |
| NCT07436754 | Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving … | Na | Mild Traumatic Brain Injury | Recruiting | 2026-05-20 | 2031-03-01 | ClinicalTrials.gov |
| NCT07605962 | Phase 1/2 Study of UI-102 in Selected Advanced Cancers | Phase1 | Advanced Cancer | Recruiting | 2026-05-20 | 2031-03-31 | ClinicalTrials.gov |
| NCT07689682 | OPM- MEG in Non-immune And iMmune-medIated Neurological Disease | Na | Autoimmune Encephalitis (AE) | Active_Not_Recruiting | 2026-05-15 | 2034-09-15 | ClinicalTrials.gov |
| NCT07600944 | Comparison of the Pharmacokinetics （PK）and Pharmacodynamics （PD）Biosimilarity o… | Na | Pharmacokinetics and Pharmacodynamics | Completed | 2026-05-06 | 2026-07-03 | ClinicalTrials.gov |
| NCT07590063 | Technology Development of Diagnostic Ultrasound System for Obstetric Imaging | — | Pregnancy | Not_Yet_Recruiting | 2026-05-06 | 2026-09-30 | ClinicalTrials.gov |
| NCT07280351 | Duraplasty for Acute Traumatic Spinal Cord Injury | Na | Spinal Cord Injury, Acute | Enrolling_By_Invitation | 2026-05-04 | 2029-06-01 | ClinicalTrials.gov |
| NCT07022808 | Tele-Exercise to Promote Empowered Movement in Individuals With Spinal Cord Inj… | Na | Spinal Cord Injury | Recruiting | 2026-05-04 | 2029-08-31 | ClinicalTrials.gov |
| NCT07741929 | Patient and Provider Perspectives on Genetic Risk Profiling | — | Prostate Cancer | Recruiting | 2026-05-01 | 2027-08-31 | ClinicalTrials.gov |
| NCT07220681 | Integrated Health Care for PTSD | Na | Posttraumatic Stress Disorder (PTSD) | Recruiting | 2026-04-23 | 2029-09-30 | ClinicalTrials.gov |
| NCT07165678 | CTCA Prior to Invasive Angiography in Post-Bypass Patients (BYPASS CTCA 2) | Na | Coronary Heart Disease | Recruiting | 2026-04-16 | 2029-07-31 | ClinicalTrials.gov |
| NCT07300462 | A Post-marketing Observational Study of Oral Cholera Vaccine | Phase4 | Diarrhea | Enrolling_By_Invitation | 2026-04-10 | 2027-01-01 | ClinicalTrials.gov |
| NCT07629596 | Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an m… | Early_Phase1 | Systemic Lupus Erythematosus | Recruiting | 2026-04-07 | 2027-05-30 | ClinicalTrials.gov |
| NCT07112508 | PRISM: The PRimary Care Individual Social Norms MSK Data Dashboard: a Feasibili… | Na | Musculoskeletal Disorders | Recruiting | 2026-04-01 | 2027-11-01 | ClinicalTrials.gov |
| NCT07637331 | The Effect of Respiratory Muscle Training on Cognitive Performance | Na | Respiratory Muscle Training | Recruiting | 2026-03-27 | 2027-04-01 | ClinicalTrials.gov |
| NCT05987956 | Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polym… | Phase2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | Active_Not_Recruiting | 2026-03-18 | 2026-12-28 | ClinicalTrials.gov |
| NCT07144826 | Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patien… | Early_Phase1 | Advanced Ovarian Carcinoma | Recruiting | 2026-03-06 | 2027-07-09 | ClinicalTrials.gov |
| NCT07451951 | Effectiveness of Small-Quantity vs Medium-Quantity Lipid-Based Nutrient Supplem… | Na | Undernutrition | Recruiting | 2026-02-26 | 2028-12-31 | ClinicalTrials.gov |
| NCT07406997 | Rehabilitation With Empowered STrategies to Optimize REcovery | Na | Lumbar Spine Degenerative Changes | Recruiting | 2026-02-24 | 2029-08-31 | ClinicalTrials.gov |
| NCT06871410 | Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed o… | Phase1 | Recurrent Acute Myeloid Leukemia | Recruiting | 2026-02-02 | 2028-04-01 | ClinicalTrials.gov |
| NCT07413991 | Expressive Writing Program Among Young Adults With Blood Cancer | Na | Hematologic Malignancy | Active_Not_Recruiting | 2026-02-01 | 2026-08-30 | ClinicalTrials.gov |
| NCT07373509 | Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injur… | — | TBI (Traumatic Brain Injury) | Recruiting | 2026-01-13 | 2030-04-01 | ClinicalTrials.gov |
| NCT06503406 | A Prospective Study Using SupraSDRM® in Promoting Healing and Reducing the Time… | Na | Surgical Wound | Recruiting | 2026-01-08 | 2027-12-01 | ClinicalTrials.gov |
| NCT07233408 | Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neu… | Na | Neurofibromatosis 1 | Recruiting | 2025-12-28 | 2027-05-30 | ClinicalTrials.gov |
| NCT06961084 | Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer | Phase2 | Thyroid Cancer | Recruiting | 2025-12-04 | 2028-04-01 | ClinicalTrials.gov |
| NCT07102433 | Complexity in Health, Education, and Social Support for Children and Young Peop… | — | Complex Care | Recruiting | 2025-12-01 | 2026-09-30 | ClinicalTrials.gov |
| NCT07742306 | Continuous Glucose Monitoring in High-Risk Children and Youth With Type 1 Diabe… | — | Type 1 Diabetes (T1D) | Recruiting | 2025-11-14 | 2027-12-01 | ClinicalTrials.gov |
| NCT07217171 | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104… | Phase1 | Bladder Cancer | Recruiting | 2025-11-13 | 2031-01-29 | ClinicalTrials.gov |
| NCT07115563 | Daily Amino Acid Supplementation for People With Parkinson's Disease | Na | Parkinson Disease (PD) | Recruiting | 2025-10-31 | 2027-11-01 | ClinicalTrials.gov |
| NCT06878560 | Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients W… | Phase1 | ESRD (End-Stage Renal Disease) | Recruiting | 2025-10-29 | 2075-10-01 | ClinicalTrials.gov |
| NCT07589855 | Somatosensory Stimulation for Unilateral Neglect Post Stroke (SSUN) | Na | Stroke | Recruiting | 2025-10-20 | 2026-07-01 | ClinicalTrials.gov |
| NCT07187817 | SEquential Treatment of PSoriasis With Biologics | — | Psoriasis | Recruiting | 2025-10-14 | 2026-08-07 | ClinicalTrials.gov |
| NCT07047807 | PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Ini… | Na | PDAC - Pancreatic Ductal Adenocarcinoma | Recruiting | 2025-10-06 | 2027-08-01 | ClinicalTrials.gov |
| NCT07116681 | Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pul… | Early_Phase1 | Pulmonary Hypertension | Not_Yet_Recruiting | 2025-10-01 | 2027-07-01 | ClinicalTrials.gov |
| NCT07037836 | Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia | Phase2 | COPD (Chronic Obstructive Pulmonary Disease) | Recruiting | 2025-09-29 | 2027-07-01 | ClinicalTrials.gov |
| NCT07103200 | Evaluation of Decision-Making Fatigue After Traumatic Brain Injury | Na | TBI (Traumatic Brain Injury) | Recruiting | 2025-09-24 | 2029-07-15 | ClinicalTrials.gov |
| NCT07166120 | Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patie… | Na | Smoking Cessation | Recruiting | 2025-09-11 | 2027-09-30 | ClinicalTrials.gov |
| NCT07207408 | Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 5… | Phase2 | Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis | Recruiting | 2025-09-11 | 2027-08-31 | ClinicalTrials.gov |
| NCT06833320 | Propranolol Treatment for Postoperative Chylothorax | Phase1 | Postoperative Chylothorax | Suspended | 2025-09-09 | 2031-01-01 | ClinicalTrials.gov |
| NCT06866262 | Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Me… | Phase1 | Locally Advanced Clear Cell Renal Cell Carcinoma | Recruiting | 2025-08-15 | 2031-08-01 | ClinicalTrials.gov |
| NCT07608692 | Comparative Clinical Trial of Pharmacokinetics and Pharmacodynamics of Human In… | Phase1 | Pharmacokinetics and Pharmacodynamics | Completed | 2025-08-04 | 2026-01-13 | ClinicalTrials.gov |
| NCT06911632 | Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring… | Na | Pulmonary Hypertension | Recruiting | 2025-07-23 | 2028-07-01 | ClinicalTrials.gov |
| NCT06940609 | Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimula… | Phase2 | Long COVID | Recruiting | 2025-07-07 | 2029-06-30 | ClinicalTrials.gov |
| NCT06942104 | Imaging of Solid Tumors Using 18F-TRX | Phase1 | Solid Tumor | Recruiting | 2025-07-03 | 2027-09-30 | ClinicalTrials.gov |
| NCT06446609 | Drug-induced Liver Injury: Itching Study | — | Drug Induced Liver Injury | Recruiting | 2025-06-30 | 2028-05-01 | ClinicalTrials.gov |
| NCT06419920 | Prosthetic Performance Enhancement Trial | Na | Amputation | Recruiting | 2025-06-26 | 2027-07-01 | ClinicalTrials.gov |
| NCT07034352 | Health Impact 360: Advancing Physical, Social, and Mental Health Toward Cardiov… | Na | Health Promotion | Recruiting | 2025-06-20 | 2026-12-01 | ClinicalTrials.gov |
| NCT07064551 | Evaluation Study of Medical-Social Collaboration Model for Middle-aged and Olde… | Na | Depression | Recruiting | 2025-06-20 | 2027-06-01 | ClinicalTrials.gov |
| NCT06844617 | A Trial of Staff Time With Proned Patients in the ICU Using the 'BathMat' | Na | Acute Respiratory Distress Syndrome (ARDS) | Completed | 2025-06-05 | 2026-08-04 | ClinicalTrials.gov |
| NCT06826924 | 7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer | Na | Prostate Cancer | Recruiting | 2025-06-03 | 2027-06-03 | ClinicalTrials.gov |
| NCT03305341 | Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation … | Early_Phase1 | Covid19 | Active_Not_Recruiting | 2025-05-18 | 2026-12-28 | ClinicalTrials.gov |
| NCT06652438 | Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated… | Phase3 | Acute Myeloid Leukemia, Adult | Recruiting | 2025-05-05 | 2032-08-27 | ClinicalTrials.gov |
| NCT06701019 | Exploring Breast Referral Behaviours in Primary Care | Na | Breast Cancer Female | Completed | 2025-05-01 | 2026-01-31 | ClinicalTrials.gov |
| NCT07652580 | Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma | — | Non-Hodgkin Lymphoma | Recruiting | 2025-05-01 | 2028-05-01 | ClinicalTrials.gov |
| NCT06609265 | Extracorporeal Shockwave Therapy (ESWT) for the Management of Stress Fractures … | Na | Bones Stress Injury | Recruiting | 2025-05-01 | 2027-11-01 | ClinicalTrials.gov |
| NCT06959563 | Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treatin… | Early_Phase1 | HPV Infection | Active_Not_Recruiting | 2025-04-28 | 2026-10-28 | ClinicalTrials.gov |
| NCT06656702 | Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis | Early_Phase1 | Amyotrophic Lateral Sclerosis | Recruiting | 2025-04-09 | 2027-07-01 | ClinicalTrials.gov |
| NCT06771713 | Brief Pain Reprocessing Therapy in Veterans | Na | Chronic Lower Back Pain (CLBP) | Recruiting | 2025-03-10 | 2027-06-01 | ClinicalTrials.gov |
| NCT06322953 | Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemo… | Phase3 | Traumatic Intracranial Haemorrhage | Recruiting | 2025-03-10 | 2028-07-31 | ClinicalTrials.gov |
| NCT06201676 | Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polyt… | Phase4 | Orthopaedic Trauma | Recruiting | 2025-02-28 | 2027-08-31 | ClinicalTrials.gov |
| NCT06819904 | Acceptance and Commitment Therapy Integrated Vestibular Rehabilitation (ACTIVE)… | Na | Concussion, Mild | Recruiting | 2025-02-27 | 2027-08-01 | ClinicalTrials.gov |
| NCT05093231 | Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer | Phase2 | Pancreatic Cancer | Recruiting | 2025-02-26 | 2028-01-01 | ClinicalTrials.gov |
| NCT07691268 | Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006… | Phase1 | Dyslipidemia | Completed | 2025-02-13 | 2025-03-26 | ClinicalTrials.gov |
| NCT06275282 | Regenerative Peripheral Nerve Interface for Control of Lower Limb Prostheses | Na | Amputation | Recruiting | 2025-02-13 | 2027-09-30 | ClinicalTrials.gov |
| NCT06588608 | Auricular Vagus Nerve Stimulation (aVNS) in Chronic Spinal Cord Injuries (SCI) | Na | Spinal Cord Injuries | Completed | 2025-02-04 | 2026-04-24 | ClinicalTrials.gov |
| NCT06388421 | DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension A… | — | Pulmonary Hypertension Due to Lung Diseases and Hypoxia | Recruiting | 2025-01-23 | 2030-11-30 | ClinicalTrials.gov |
| NCT06380179 | Photomedicine Project 14: PBMT for Performance Enhancement in SOF | Na | Photobiomodulation Therapy | Completed | 2025-01-23 | 2026-03-02 | ClinicalTrials.gov |
| NCT06253715 | Shortened Regimen for Drug-susceptible TB in Children | Phase3 | Tuberculosis | Recruiting | 2025-01-15 | 2027-09-30 | ClinicalTrials.gov |
| NCT06450041 | NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and … | Phase2 | Neuroblastoma | Recruiting | 2024-12-16 | 2038-12-01 | ClinicalTrials.gov |
| NCT06681896 | Microvascular Coronary Rehabilitation For Improving Treatment - Feasibility Stu… | Na | Microvascular Coronary Dysfunction | Recruiting | 2024-11-12 | 2027-08-01 | ClinicalTrials.gov |
| NCT06544408 | Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation | Na | Post Traumatic Stress Disorder | Recruiting | 2024-11-06 | 2028-12-30 | ClinicalTrials.gov |
| NCT05771675 | Simvastatin Treatment to Improve Patient-reported Outcomes in Patients With Chr… | Early_Phase1 | Recurrent Acute Pancreatitis | Recruiting | 2024-10-24 | 2028-06-01 | ClinicalTrials.gov |
| NCT06687746 | Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based S… | — | Jaundice, Neonatal | Completed | 2024-10-24 | 2026-03-03 | ClinicalTrials.gov |
| NCT06293300 | Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia … | Phase2 | Traumatic Brain Injury | Recruiting | 2024-09-30 | 2027-09-30 | ClinicalTrials.gov |
| NCT06520072 | Mobile Apps for Preschool Parents (MAPP) Study | Na | Obesity, Childhood | Completed | 2024-08-01 | 2024-11-19 | ClinicalTrials.gov |
| NCT06477640 | Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension | Na | Pulmonary Arterial Hypertension PAH | Active_Not_Recruiting | 2024-07-29 | 2026-12-31 | ClinicalTrials.gov |
| NCT06185686 | Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brai… | — | Brain Tumor, Primary | Recruiting | 2024-07-10 | 2027-07-31 | ClinicalTrials.gov |
| NCT05958342 | CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial | Phase2 | Trauma | Recruiting | 2024-06-30 | 2028-03-01 | ClinicalTrials.gov |
| NCT06430086 | Mechanistic Effect of Walnut Consumption on Sleep Quality | Na | Poor Sleep Quality | Recruiting | 2024-06-28 | 2026-12-31 | ClinicalTrials.gov |
| NCT06017934 | Promoting Increased Physical Activity in Hospitalised Older Adults | Na | Hospital-associated Deconditioning | Recruiting | 2024-06-06 | 2026-11-01 | ClinicalTrials.gov |
| NCT06282965 | Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Tra… | Phase1 | Traumatic Brain Injury | Recruiting | 2024-05-28 | 2027-09-01 | ClinicalTrials.gov |
| NCT06478524 | Music Intervention for Dialysis Patients | Na | Renal Failure | Completed | 2024-05-27 | 2024-06-22 | ClinicalTrials.gov |
| NCT06100822 | Managing Chronic Tendon Pain by Metformin | Phase1 | Tendinopathy | Recruiting | 2024-05-24 | 2026-09-30 | ClinicalTrials.gov |
| NCT06425796 | Adiposity and Iron Requirements in Pregnancy | Na | Iron Deficiency Anemia of Pregnancy | Recruiting | 2024-05-20 | 2027-03-19 | ClinicalTrials.gov |
| NCT06406855 | Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cor… | Na | Spinal Cord Injuries | Recruiting | 2024-05-07 | 2026-12-31 | ClinicalTrials.gov |
| NCT06397989 | Peanut-based School Meals in Rural Ghana to Improve Attendance and Retention | Na | School Attendance | Completed | 2024-05-07 | 2026-07-31 | ClinicalTrials.gov |
| NCT06237127 | Effects of Goji vs. Fiber on Macular Degeneration | Na | Age-Related Macular Degeneration | Recruiting | 2024-04-29 | 2027-12-31 | ClinicalTrials.gov |
| NCT06145035 | Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTr… | Phase2 | Ischemic Heart Disease | Recruiting | 2024-03-04 | 2028-09-01 | ClinicalTrials.gov |
| NCT06560853 | Evaluation of a Comprehensive School Health Programme in Zambia | Na | Malaria | Active_Not_Recruiting | 2024-02-27 | 2026-11-30 | ClinicalTrials.gov |
| NCT06285708 | Enhancing the Effectiveness of Prolonged Exposure Among Suicidal Individuals Wi… | Na | PTSD | Recruiting | 2024-02-26 | 2027-06-01 | ClinicalTrials.gov |
| NCT05759013 | Pivotal Evaluation of Abdominal Neuromuscular Electrical Stimulation (VentFree)… | Na | Respiration, Artificial | Completed | 2024-02-15 | 2026-05-01 | ClinicalTrials.gov |
| NCT05340426 | Porcine Kidney Xenotransplantation in Patients With End-Stage Kidney Disease | Phase1 | Kidney Failure, Chronic | Withdrawn | 2024-01-31 | 2029-06-30 | ClinicalTrials.gov |
| NCT05581121 | PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer | Phase3 | Cervical Carcinoma | Recruiting | 2023-12-20 | 2033-12-20 | ClinicalTrials.gov |
| NCT06087133 | Prenatal Starting Early Program mHealth | Na | Pregnancy | Active_Not_Recruiting | 2023-12-08 | 2026-10-31 | ClinicalTrials.gov |
| NCT05570851 | Alcohol Cessation Among Head and Neck Cancer Survivors | Na | Head and Neck Cancer | Completed | 2023-12-01 | 2026-03-23 | ClinicalTrials.gov |
| NCT06038149 | Improving Pulmonary Hypertension Screening by Echocardiography | — | Pulmonary Hypertension | Active_Not_Recruiting | 2023-11-11 | 2026-09-22 | ClinicalTrials.gov |
| NCT06087445 | A User-friendly, Non-invasive Neuro-orthosis That Restores Volitionally Control… | Na | Cervical Spinal Cord Injury | Completed | 2023-10-31 | 2026-05-11 | ClinicalTrials.gov |
| NCT05943535 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progr… | Phase3 | Progressive Pulmonary Fibrosis | Recruiting | 2023-10-30 | 2027-11-01 | ClinicalTrials.gov |
| NCT07735052 | Drug-drug Interaction Study Between UIC202304, and UIC202305 | Phase1 | Healhty | Completed | 2023-09-25 | 2024-09-09 | ClinicalTrials.gov |
| NCT05684692 | Screening Trial for Pain Relief in Schwannomatosis (STARFISH) | Phase2 | Schwannomatosis | Recruiting | 2023-08-31 | 2028-11-30 | ClinicalTrials.gov |
| NCT05620719 | Multisite Advancement of Research on Chronic Posttraumatic Headache | Na | Posttraumatic Headache | Recruiting | 2023-08-24 | 2027-08-01 | ClinicalTrials.gov |
| NCT06001268 | Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) | Na | Pancreatic Cancer | Active_Not_Recruiting | 2023-08-14 | 2027-08-01 | ClinicalTrials.gov |
| NCT05776225 | Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for… | — | Interstitial Lung Disease | Completed | 2023-08-11 | 2026-04-29 | ClinicalTrials.gov |
| NCT05359653 | Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fuma… | Phase1 | Multiple Sclerosis (MS) | Recruiting | 2023-08-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT05933681 | Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain S… | Na | Parkinson Disease | Active_Not_Recruiting | 2023-07-06 | 2027-05-01 | ClinicalTrials.gov |
| NCT05060315 | Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodul… | — | Pulmonary Arterial Hypertension | Terminated | 2023-07-05 | 2024-12-31 | ClinicalTrials.gov |
| NCT05194293 | Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer | Phase2 | Stage IB Hepatocellular Carcinoma AJCC v8 | Active_Not_Recruiting | 2023-07-01 | 2028-12-05 | ClinicalTrials.gov |
| NCT05795764 | Crisis Response Planning for Military Personnel | Na | Suicidal | Active_Not_Recruiting | 2023-06-21 | 2027-03-31 | ClinicalTrials.gov |
| NCT05699174 | PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After … | Phase3 | Infections | Recruiting | 2023-05-30 | 2028-09-29 | ClinicalTrials.gov |
| NCT06081543 | Ketogenic Diet vs Mixed Diet in Patients With Heart Failure | Na | Heart Failure With Preserved Ejection Fraction | Recruiting | 2023-05-19 | 2026-08-31 | ClinicalTrials.gov |
| NCT05658731 | Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pedi… | Na | Brain Tumor | Recruiting | 2023-05-17 | 2035-12-01 | ClinicalTrials.gov |
| NCT04586049 | Cardiovascular and Neurovascular Regulation in GWI | — | Brain Blood Flow | Active_Not_Recruiting | 2023-05-16 | 2026-12-01 | ClinicalTrials.gov |
| NCT05541250 | Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Sev… | Phase1 | Peripheral Nerve Injury | Recruiting | 2023-05-04 | 2026-09-29 | ClinicalTrials.gov |
| NCT05456607 | Digital CBT for Insomnia and Depression | Na | Depression | Recruiting | 2023-05-01 | 2027-09-18 | ClinicalTrials.gov |
| NCT05242965 | A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage I… | Phase2 | Lung Non-Small Cell Carcinoma | Recruiting | 2023-03-24 | 2032-11-21 | ClinicalTrials.gov |
| NCT05564637 | A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertensi… | Phase2 | Pulmonary Arterial Hypertension | Completed | 2023-03-13 | 2024-10-30 | ClinicalTrials.gov |
| NCT05687188 | Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority… | — | Pancreatic Cancer | Recruiting | 2023-02-22 | 2026-12-01 | ClinicalTrials.gov |
| NCT05521126 | Micro-Doppler Radar: A Gold Standard Comparison | — | Musculoskeletal Injury | Active_Not_Recruiting | 2023-02-21 | 2026-08-01 | ClinicalTrials.gov |
| NCT05199285 | A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Pr… | Phase2 | BCLC Stage B Hepatocellular Carcinoma | Terminated | 2023-01-19 | 2026-02-01 | ClinicalTrials.gov |
| NCT05378100 | Ketamine for Multiple Sclerosis Fatigue | Phase2 | Multiple Sclerosis Fatigue | Active_Not_Recruiting | 2023-01-01 | 2026-10-01 | ClinicalTrials.gov |
| NCT04348747 | Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment o… | Phase2 | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting | 2022-12-19 | 2028-05-15 | ClinicalTrials.gov |
| NCT05421897 | Rapid Administration Pilot for Infusing Dinutuximab | Phase1 | Neuroblastoma | Active_Not_Recruiting | 2022-11-29 | 2026-01-01 | ClinicalTrials.gov |
| NCT05111925 | Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty En… | — | Musculoskeletal Injuries | Recruiting | 2022-10-26 | 2028-05-31 | ClinicalTrials.gov |
| NCT05203510 | A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Ra… | Phase4 | Pulmonary Arterial Hypertension | Active_Not_Recruiting | 2022-10-20 | 2028-04-30 | ClinicalTrials.gov |
| NCT05255991 | Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects … | Phase3 | Idiopathic Pulmonary Fibrosis | Completed | 2022-10-04 | 2025-06-30 | ClinicalTrials.gov |
| NCT04905693 | Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease | Phase3 | Idiopathic Pulmonary Fibrosis | Enrolling_By_Invitation | 2022-09-06 | 2029-12-01 | ClinicalTrials.gov |
| NCT05371496 | Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ej… | Phase4 | Cardiomyopathy | Completed | 2022-09-06 | 2026-07-17 | ClinicalTrials.gov |
| NCT05368298 | SCOOT: Sample Collection for DART | — | Lung Cancer | Active_Not_Recruiting | 2022-08-11 | 2027-09-30 | ClinicalTrials.gov |
| NCT05024760 | Antiseptic Effects on the Dental Implant Internal Surface Microbiome | Early_Phase1 | Peri-Implantitis | Completed | 2022-07-28 | 2026-05-01 | ClinicalTrials.gov |
| NCT04589611 | Translating Metabolic Responses to Mechanical Insult Into Early Interventions t… | Phase1 | Osteoarthritis | Terminated | 2022-07-20 | 2025-05-01 | ClinicalTrials.gov |
| NCT05168163 | Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of … | Phase2 | Locally Advanced Hepatocellular Carcinoma | Recruiting | 2022-05-27 | 2026-12-31 | ClinicalTrials.gov |
| NCT04329065 | Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antib… | Phase2 | Anatomic Stage I Breast Cancer AJCC v8 | Recruiting | 2022-04-20 | 2027-12-31 | ClinicalTrials.gov |
| NCT04748549 | Intraoperative VR for Older Patients Undergoing TKA | Na | Total Knee Arthroplasty | Completed | 2022-04-11 | 2026-06-01 | ClinicalTrials.gov |
| NCT04754165 | Postoperative VR for Recovery After Bariatric Surgery | Na | Bariatric Surgery Candidate | Active_Not_Recruiting | 2022-03-21 | 2027-06-30 | ClinicalTrials.gov |
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | Phase1 | Advanced Cancer | Active_Not_Recruiting | 2022-03-02 | 2026-12-01 | ClinicalTrials.gov |
| NCT05823766 | Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epilepto… | — | Traumatic Brain Injury | Active_Not_Recruiting | 2022-03-01 | 2027-02-01 | ClinicalTrials.gov |
| NCT05137743 | Pilot Test of Apnea and Insomnia Relief for Veterans With Gulf War Illness | Na | Gulf War Illness | Completed | 2022-02-15 | 2026-03-11 | ClinicalTrials.gov |
| NCT05176808 | Telehealth Parent-Implemented Intervention for Young Children With Autism Spect… | Na | Autism Spectrum Disorder | Completed | 2022-02-07 | 2026-04-10 | ClinicalTrials.gov |
| NCT04802590 | Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Ma… | Phase2 | Mantle Cell Lymphoma | Active_Not_Recruiting | 2022-01-24 | 2031-09-30 | ClinicalTrials.gov |
| NCT04964947 | Tobramycin Injection to Prevent Infection in Open Fractures | Phase3 | Wound Infection | Active_Not_Recruiting | 2022-01-10 | 2026-07-01 | ClinicalTrials.gov |
| NCT02403505 | Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treatin… | Phase1 | Rectal Cancer | Active_Not_Recruiting | 2021-12-28 | 2026-12-28 | ClinicalTrials.gov |
| NCT05216016 | Minnesota RETAIN Phase 2 (Sub-study) | Na | Injuries Related Work | Completed | 2021-12-23 | 2026-05-16 | ClinicalTrials.gov |
| NCT04989946 | Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Check… | Phase1 | Prostate Cancer | Active_Not_Recruiting | 2021-12-16 | 2028-12-01 | ClinicalTrials.gov |
| NCT04692818 | 3D Ultrasound Breast Imaging | Na | Breast Tumor | Recruiting | 2021-11-10 | 2026-12-31 | ClinicalTrials.gov |
| NCT05080946 | Using Aspirin to Improve Immunological Features of Ovarian Tumors | Early_Phase1 | Ovarian Cancer | Recruiting | 2021-11-02 | 2026-12-01 | ClinicalTrials.gov |
| NCT05167981 | RETAINWORKS Impact Evaluation | Na | Disability | Completed | 2021-10-22 | 2026-02-28 | ClinicalTrials.gov |
| NCT05173350 | RETAIN Kentucky Impact Evaluation | Na | Disability | Completed | 2021-10-18 | 2026-02-28 | ClinicalTrials.gov |
| NCT04674306 | Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Ca… | Early_Phase1 | Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer | Completed | 2021-10-01 | 2025-12-29 | ClinicalTrials.gov |
| NCT04850105 | A Non-interventional Cohort Safety Study of Patients With hATTR-PN | — | Hereditary Transthyretin Amyloidosis With Polyneuropthy | Active_Not_Recruiting | 2021-09-21 | 2036-03-31 | ClinicalTrials.gov |
| NCT04394533 | Hyperbaric Prilocaine Compared With Hyperbaric Bupivacaine in Cervical Cerclage? | Phase4 | Cervical Incompetence in Pregnancy as Antepartum Condition | Completed | 2021-08-27 | 2025-08-20 | ClinicalTrials.gov |
| NCT04626791 | Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Tr… | Phase2 | Mantle Cell Lymphoma | Active_Not_Recruiting | 2021-08-03 | 2028-08-03 | ClinicalTrials.gov |
| NCT04597008 | Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fra… | Phase3 | Post Operative Surgical Site Infection | Completed | 2021-06-18 | 2025-07-30 | ClinicalTrials.gov |
| NCT04708782 | Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathi… | Phase3 | Idiopathic Pulmonary Fibrosis | Completed | 2021-06-01 | 2026-02-02 | ClinicalTrials.gov |
| NCT04678154 | Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open F… | Phase3 | Post Operative Surgical Site Infection | Recruiting | 2021-05-07 | 2029-03-31 | ClinicalTrials.gov |
| NCT07737509 | Understanding the Genetic and Biological Factors That Influence Cancer Treatmen… | — | Advanced Solid Tumours | Recruiting | 2021-04-28 | 2036-06-01 | ClinicalTrials.gov |
| NCT04356859 | The Acute Burn ResUscitation Multicenter Prospective Trial | Na | Burn Injury | Completed | 2021-04-22 | 2025-09-29 | ClinicalTrials.gov |
| NCT04387227 | Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian… | Phase2 | Recurrent Fallopian Tube Carcinoma | Completed | 2021-03-18 | 2026-06-01 | ClinicalTrials.gov |
| NCT04722835 | Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Dise… | — | Copd | Recruiting | 2021-03-01 | 2030-12-31 | ClinicalTrials.gov |
| NCT04762888 | 68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer | Phase2 | Hepatocellular Carcinoma | Completed | 2021-02-24 | 2025-06-26 | ClinicalTrials.gov |
| NCT04481048 | Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis T… | Phase2 | Neurofibromatosis 1 | Completed | 2021-02-23 | 2024-06-25 | ClinicalTrials.gov |
| NCT04641026 | Discovery of Biological Signatures for Cruciferous Vegetable Intake (Single Ser… | Na | Diet, Healthy | Active_Not_Recruiting | 2021-02-22 | 2027-12-01 | ClinicalTrials.gov |
| NCT04084678 | Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CP… | Phase3 | Pulmonary Hypertension | Terminated | 2021-01-20 | 2023-04-12 | ClinicalTrials.gov |
| NCT04005469 | Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusi… | Phase1 | Ischemia Reperfusion Injury | Recruiting | 2020-11-13 | 2028-06-30 | ClinicalTrials.gov |
| NCT04368117 | STAT: Standard Therapy Plus Active Therapy | Na | Burn Injury | Active_Not_Recruiting | 2020-10-26 | 2026-09-29 | ClinicalTrials.gov |
| NCT04416412 | ICG Fluorescence Imaging in Open Fracture Trauma Patients | — | Trauma Injury | Completed | 2020-10-01 | 2026-07-01 | ClinicalTrials.gov |
| NCT04363164 | Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression | Phase2 | Castration Resistant Metastatic Prostate Cancer | Recruiting | 2020-08-19 | 2028-07-01 | ClinicalTrials.gov |
| NCT04430218 | Peripheral Interfaces in Amputees for Sensorimotor Integration | Na | Upper Extremity Amputee | Recruiting | 2020-08-18 | 2032-06-30 | ClinicalTrials.gov |
| NCT03833323 | Implantable System for Remodulin Post-Approval Study | — | Pulmonary Arterial Hypertension | Withdrawn | 2020-08-01 | 2021-06-30 | ClinicalTrials.gov |
| NCT04042831 | Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberran… | Phase2 | Bile Duct Adenocarcinoma | Active_Not_Recruiting | 2020-06-24 | 2026-08-30 | ClinicalTrials.gov |
| NCT04246281 | The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatmen… | Na | Low Back Pain | Completed | 2020-06-17 | 2026-04-27 | ClinicalTrials.gov |
| NCT04023591 | Nerve Transfer After Spinal Cord Injury- Multi-center | — | Tetraplegia | Active_Not_Recruiting | 2020-04-13 | 2030-12-01 | ClinicalTrials.gov |
| NCT03814317 | Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension | Phase2 | Sarcoidosis | Completed | 2020-01-30 | 2025-12-31 | ClinicalTrials.gov |
| NCT03873610 | Resiliency Training in Adolescents With NF1 and NF2 | Na | Neurofibromatoses | Completed | 2019-12-15 | 2026-02-20 | ClinicalTrials.gov |
| NCT04090866 | Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary A… | — | Pulmonary Arterial Hypertension | Terminated | 2019-11-14 | 2020-07-21 | ClinicalTrials.gov |
| NCT03796884 | Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer | Phase2 | Colorectal Adenoma | Active_Not_Recruiting | 2019-10-30 | 2026-09-30 | ClinicalTrials.gov |
| NCT03857841 | A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Pret… | Phase1 | Bronchopulmonary Dysplasia | Terminated | 2019-10-09 | 2021-05-20 | ClinicalTrials.gov |
| NCT03433183 | SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhib… | Phase2 | Malignant Peripheral Nerve Sheath Tumors | Completed | 2019-10-02 | 2023-10-01 | ClinicalTrials.gov |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects W… | Phase3 | PAH | Enrolling_By_Invitation | 2019-09-23 | 2026-12-01 | ClinicalTrials.gov |
| NCT03950739 | Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in S… | Phase1 | Pulmonary Arterial Hypertension | Completed | 2019-09-17 | 2023-08-22 | ClinicalTrials.gov |
| NCT03947450 | Autologous Volar Fibroblast Injection Into the Stump Site of Amputees | Phase2 | Amputation | Recruiting | 2019-09-05 | 2028-04-01 | ClinicalTrials.gov |
| NCT04446442 | Cerebellar tDCS in Children With Autism Spectrum Disorder | Na | Autism Spectrum Disorder | Recruiting | 2019-06-04 | 2027-12-31 | ClinicalTrials.gov |
| NCT03684278 | Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Place… | Phase2 | Acute Pancreatitis | Recruiting | 2019-05-01 | 2027-03-06 | ClinicalTrials.gov |
| NCT03582176 | PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2 | Phase3 | Elbow Fracture | Completed | 2019-04-26 | 2024-12-17 | ClinicalTrials.gov |
| NCT03888365 | Patient Global Impression Questions for Activity-Induced Symptoms in Participan… | — | Pulmonary Arterial Hypertension | Completed | 2019-04-01 | 2019-09-19 | ClinicalTrials.gov |
| NCT07600385 | A Study to Evaluate the Efficacy and Safety of UI022/UI023 | Phase3 | Peripheral Arterial Disease | Completed | 2019-03-12 | 2022-05-03 | ClinicalTrials.gov |
| NCT03890237 | GAGE Act With Her-Ethiopia Evaluation | Na | Adolescent Behavior | Active_Not_Recruiting | 2019-03-01 | 2026-11-30 | ClinicalTrials.gov |
| NCT03497689 | EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to … | Phase4 | Pulmonary Arterial Hypertension | Completed | 2019-01-31 | 2022-05-11 | ClinicalTrials.gov |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Ou… | Phase3 | PAH | Completed | 2019-01-24 | 2025-12-31 | ClinicalTrials.gov |
| NCT02573896 | Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells | Phase1 | Neuroblastoma | Active_Not_Recruiting | 2019-01-14 | 2026-12-01 | ClinicalTrials.gov |
| NCT03794583 | Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic… | Phase3 | Pulmonary Hypertension | Terminated | 2018-12-21 | 2022-11-29 | ClinicalTrials.gov |
| NCT03332667 | MIBG With Dinutuximab +/- Vorinostat | Phase1 | Neuroblastoma | Completed | 2018-09-12 | 2024-02-23 | ClinicalTrials.gov |
| NCT03496623 | A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Trepros… | Phase3 | Pulmonary Hypertension | Terminated | 2018-05-08 | 2022-10-13 | ClinicalTrials.gov |
| NCT03531073 | Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic A… | — | Psoriatic Arthritis | Completed | 2018-04-18 | 2024-12-31 | ClinicalTrials.gov |
| NCT03367312 | Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI | Phase2 | Pulmonary Vascular Disease | Completed | 2018-03-29 | 2022-11-01 | ClinicalTrials.gov |
| NCT03197675 | Acupuncture in Spinal Cord Injury Subjects | Na | Spinal Cord Injuries | Completed | 2018-03-14 | 2023-02-16 | ClinicalTrials.gov |
| NCT03417388 | Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD | Phase4 | Coronary Artery Disease | Active_Not_Recruiting | 2018-02-09 | 2026-09-14 | ClinicalTrials.gov |
| NCT03043651 | Open-label Extension of Oral Treprostinil in Subjects With PH Associated With H… | Phase3 | Pulmonary Hypertension Associated With HFpEF | Terminated | 2018-01-30 | 2020-03-02 | ClinicalTrials.gov |
| NCT03029884 | Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain | Na | Chronic Pain | Completed | 2017-10-28 | 2026-06-30 | ClinicalTrials.gov |
| NCT02999906 | Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil)… | Phase3 | Pulmonary Arterial Hypertension | Withdrawn | 2017-10-01 | 2022-06-01 | ClinicalTrials.gov |
| NCT03037580 | Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart… | Phase3 | Pulmonary Hypertension | Terminated | 2017-08-15 | 2019-12-03 | ClinicalTrials.gov |
| NCT03045029 | ADAPT - A Patient Registry of the Real-world Use of Orenitram® | — | Pulmonary Arterial Hypertension | Active_Not_Recruiting | 2017-07-18 | 2027-03-01 | ClinicalTrials.gov |
| NCT02922894 | Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury | Phase4 | Sleep Apnea | Recruiting | 2017-06-09 | 2027-01-30 | ClinicalTrials.gov |
| NCT03098030 | Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or… | Phase2 | Small Cell Lung Cancer | Completed | 2017-06-01 | 2020-03-26 | ClinicalTrials.gov |
| NCT03055234 | Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pul… | Phase3 | Pulmonary Hypertension Associated With Sickle Cell Disease | Withdrawn | 2017-06-01 | 2022-12-01 | ClinicalTrials.gov |
| NCT02882126 | An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Su… | Phase4 | Pulmonary Arterial Hypertension | Withdrawn | 2017-06-01 | 2021-06-01 | ClinicalTrials.gov |
| NCT03016468 | Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Sym… | Phase2 | Pulmonary Arterial Hypertension | Withdrawn | 2017-05-01 | 2018-09-01 | ClinicalTrials.gov |
| NCT03012646 | Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD | Phase2 | Pulmonary Hypertension | Withdrawn | 2017-04-01 | 2019-04-01 | ClinicalTrials.gov |
| NCT03012100 | Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphami… | Phase2 | Bilateral Breast Carcinoma | Active_Not_Recruiting | 2017-03-31 | 2026-07-31 | ClinicalTrials.gov |
| NCT02630316 | Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE | Phase2 | Pulmonary Hypertension | Completed | 2017-02-03 | 2019-12-26 | ClinicalTrials.gov |
| NCT02893995 | Safety, Tolerability, Pharmacokinetics and Efficacy of Two Different Rates of S… | Phase4 | Pulmonary Arterial Hypertension | Withdrawn | 2017-02-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT02663895 | Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Pati… | Phase2 | Systemic Sclerosis | Completed | 2016-10-01 | 2020-05-13 | ClinicalTrials.gov |
| NCT02633293 | An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With… | Phase2 | Pulmonary Hypertension | Terminated | 2016-09-15 | 2021-08-01 | ClinicalTrials.gov |
| NCT04056312 | Modified Story Memory Technique (mSMT) in Persons With TBI | Na | Traumatic Brain Injury | Completed | 2016-06-29 | 2022-06-30 | ClinicalTrials.gov |
| NCT02792114 | T-Cell Therapy for Advanced Breast Cancer | Phase1 | Breast Cancer | Active_Not_Recruiting | 2016-06-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT02583789 | Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or… | Early_Phase1 | Raynaud's Phenomenon | Completed | 2016-05-01 | 2021-12-31 | ClinicalTrials.gov |
| NCT02693171 | Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Ris… | — | Neuroblastoma | Terminated | 2016-03-15 | 2016-12-19 | ClinicalTrials.gov |
| NCT02603068 | Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmo… | Phase2 | Pulmonary Hypertension | Withdrawn | 2016-02-01 | 2018-07-01 | ClinicalTrials.gov |
| NCT02793271 | Reducing Stigma Among Healthcare Providers to Improve Mental Health Services | Na | Mental Disorders | Completed | 2016-02-01 | 2018-08-31 | ClinicalTrials.gov |
| NCT02632422 | AIH-induced Walking Recovery After Subacute SCI | Na | Spinal Cord Injury | Active_Not_Recruiting | 2015-10-01 | 2027-12-30 | ClinicalTrials.gov |
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy an… | Phase3 | Germ Cell Tumor | Active_Not_Recruiting | 2015-08-06 | 2031-06-01 | ClinicalTrials.gov |
| NCT02261883 | Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertens… | Phase2 | Persistent Pulmonary Hypertension of the Newborn | Terminated | 2015-07-29 | 2023-05-17 | ClinicalTrials.gov |
| NCT02279745 | Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension | Phase2 | Pulmonary Arterial Hypertension | Completed | 2015-07-08 | 2021-03-29 | ClinicalTrials.gov |
| NCT02414269 | Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineere… | Phase1 | Malignant Pleural Disease | Active_Not_Recruiting | 2015-05-01 | 2027-04-30 | ClinicalTrials.gov |
| NCT02437227 | Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmaco… | Phase1 | Melanoma | Completed | 2015-04-15 | 2018-07-01 | ClinicalTrials.gov |
| NCT02370095 | Treprostinil Sodium Inhalation for Patients At High Risk for ARDS | Phase2 | Respiratory Distress Syndrome, Adult | Terminated | 2015-02-01 | 2017-11-07 | ClinicalTrials.gov |
| NCT01964859 | Feasibility Study for Fibroblast Autologous Skin Grafts | Phase2 | Wounds and Injuries | Recruiting | 2015-01-07 | 2028-11-01 | ClinicalTrials.gov |
| NCT02276872 | Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PA… | Phase2 | PAH | Completed | 2014-12-18 | 2017-07-20 | ClinicalTrials.gov |
| NCT02279160 | Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension | Phase2 | Pulmonary Arterial Hypertension | Completed | 2014-12-01 | 2017-06-01 | ClinicalTrials.gov |
| NCT02318758 | Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunte… | Phase1 | Healthy | Completed | 2014-09-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02149095 | Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of Tran… | Phase1 | PAH | Withdrawn | 2014-07-01 | — | ClinicalTrials.gov |
| NCT02158884 | PRIORITI-MTF Study- Testing Patient Response to the IDEO | Na | Leg Injuries | Completed | 2014-06-01 | 2018-04-01 | ClinicalTrials.gov |
| NCT01980979 | Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmon… | Na | Congenital Heart Disease | Withdrawn | 2013-11-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT02318186 | Pharmacokinetic Study of Sub-q and IV Treprostinil in Kids With Pulmonary Arter… | — | Pulmonary Arterial Hypertension | Completed | 2013-10-01 | 2017-08-01 | ClinicalTrials.gov |
| NCT01560637 | An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary … | Phase3 | Pulmonary Arterial Hypertension | Completed | 2013-09-11 | 2021-08-12 | ClinicalTrials.gov |
| NCT01934582 | A Pharmacokinetic Substudy of the TDE-PH-304 Protocol | Phase3 | Pulmonary Arterial Hypertension | Completed | 2013-08-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01795950 | Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH) | Phase1 | Pulmonary Arterial Hypertension | Terminated | 2013-04-01 | 2016-01-01 | ClinicalTrials.gov |
| NCT01767194 | Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in T… | Phase2 | Ganglioneuroblastoma | Completed | 2013-02-12 | 2022-09-30 | ClinicalTrials.gov |
| NCT01799473 | Tyvaso Dosing and Titration Evaluation: TyTRATE Registry | — | Pulmonary Arterial Hypertension | Completed | 2013-01-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT02074449 | Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose … | — | Pulmonary Arterial Hypertension | Completed | 2012-12-01 | 2015-12-01 | ClinicalTrials.gov |
| NCT01714349 | Nerve Transfer After Spinal Cord Injuries | Na | Spinal Cord Injury | Completed | 2012-10-01 | 2023-03-20 | ClinicalTrials.gov |
| NCT01592045 | ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma | Phase1 | Neuroblastoma | Completed | 2012-08-01 | 2014-06-01 | ClinicalTrials.gov |
| NCT01746485 | Three Times Daily Dosing of UT-15C | Phase1 | Healthy | Completed | 2012-07-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01560624 | Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Bac… | Phase3 | Pulmonary Arterial Hypertension | Completed | 2012-06-26 | 2018-06-24 | ClinicalTrials.gov |
| NCT01557660 | Inhaled Treprostinil for PAH: Open-label Extension | Phase3 | Pulmonary Arterial Hypertension | Withdrawn | 2012-06-01 | 2018-12-01 | ClinicalTrials.gov |
| NCT01557647 | Safety and Efficacy of Inhaled Treprostinil in Patients With PAH | Phase3 | Pulmonary Arterial Hypertension | Withdrawn | 2012-06-01 | 2016-06-01 | ClinicalTrials.gov |
| NCT01555554 | Perioperative Propranolol in Patients With Post Traumatic Stress Disorder (PTSD) | Phase4 | Post-traumatic Stress Disorder | Terminated | 2012-05-01 | 2019-06-01 | ClinicalTrials.gov |
| NCT02847260 | Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Ther… | Phase4 | Pulmonary Arterial Hypertension | Completed | 2012-04-01 | 2014-03-01 | ClinicalTrials.gov |
| NCT01588405 | Remodulin® to Oral Treprostinil Transition | Phase2 | Pulmonary Arterial Hypertension | Completed | 2012-04-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01494896 | Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching | — | Pulmonary Arterial Hypertension | Terminated | 2011-11-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01477333 | Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Rec… | Phase2 | Pulmonary Arterial Hypertension | Completed | 2011-10-01 | 2013-11-01 | ClinicalTrials.gov |
| NCT01175993 | Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adult… | Phase1 | Adult | Completed | 2011-08-24 | 2014-02-04 | ClinicalTrials.gov |
| NCT01393795 | Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients | Phase2 | Pulmonary Hypertension | Completed | 2011-08-01 | 2012-07-01 | ClinicalTrials.gov |
| NCT01494519 | Assessment of Fixation Strategies for Severe Open Tibia Fractures | Phase3 | Severe Open Fractures of the Tibia (Shin) Bone | Completed | 2011-07-01 | 2018-09-01 | ClinicalTrials.gov |
| NCT01321073 | DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study | Na | Pulmonary Arterial Hypertension | Active_Not_Recruiting | 2011-06-01 | 2032-12-01 | ClinicalTrials.gov |
| NCT01324999 | Tadalafil for Sarcoidosis Associated Pulmonary Hypertension | Phase2 | Pulmonary Hypertension | Completed | 2011-03-01 | 2013-10-01 | ClinicalTrials.gov |
| NCT01302444 | Treprostinil Combined With Tadalafil for Pulmonary Hypertension | Phase4 | Pulmonary Arterial Hypertension | Terminated | 2011-03-01 | 2012-03-01 | ClinicalTrials.gov |
| NCT01293292 | Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action | Phase4 | Osteoporosis | Completed | 2011-01-01 | 2015-08-01 | ClinicalTrials.gov |
| NCT01028651 | A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver T… | — | Portopulmonary Hypertension | Completed | 2011-01-01 | 2013-04-01 | ClinicalTrials.gov |
| NCT01266265 | Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Co… | — | Pulmonary Arterial Hypertension | Completed | 2010-12-01 | 2014-12-01 | ClinicalTrials.gov |
| NCT01260454 | The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion … | Phase2 | Pulmonary Hypertension | Completed | 2010-11-01 | 2012-04-01 | ClinicalTrials.gov |
| NCT01132937 | Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic B… | — | Traumatic Brain Injury | Completed | 2010-10-07 | — | ClinicalTrials.gov |
| NCT01326104 | Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectoderm… | Phase2 | Medulloblastoma | Completed | 2010-09-07 | 2025-03-28 | ClinicalTrials.gov |
| NCT01172496 | A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and … | Phase1 | Pulmonary Arterial Hypertension | Completed | 2010-08-01 | — | ClinicalTrials.gov |
| NCT01268553 | Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medi… | Phase4 | Pulmonary Arterial Hypertension | Completed | 2010-08-01 | 2016-10-05 | ClinicalTrials.gov |
| NCT01165476 | Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two … | Phase1 | Pulmonary Arterial Hypertension | Completed | 2010-07-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01153386 | Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Dieth… | Phase1 | Pulmonary Arterial Hypertension | Completed | 2010-07-01 | 2010-08-01 | ClinicalTrials.gov |
| NCT01140373 | Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane … | Phase1 | Prostate Cancer | Active_Not_Recruiting | 2010-06-01 | 2027-06-01 | ClinicalTrials.gov |
| NCT01131845 | The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil | Phase1 | Pulmonary Arterial Hypertension | Completed | 2010-05-01 | 2010-09-01 | ClinicalTrials.gov |
| NCT01104870 | A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary … | Phase2 | Pulmonary Hypertension | Completed | 2010-04-01 | 2013-01-01 | ClinicalTrials.gov |
| NCT01042158 | A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertensio… | Phase4 | Pulmonary Arterial Hypertension | Completed | 2010-01-01 | 2014-11-01 | ClinicalTrials.gov |
| NCT01043627 | Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) | — | Pulmonary Arterial Hypertension | Completed | 2009-12-01 | 2011-12-01 | ClinicalTrials.gov |
| NCT00848107 | Open-Label Study of Oral Treprostinil in Digital Ulcers | Phase2 | Systemic Sclerosis | Terminated | 2009-09-01 | 2011-09-01 | ClinicalTrials.gov |
| NCT00963027 | Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil | Phase1 | Hypertension, Pulmonary | Completed | 2009-09-01 | 2009-10-01 | ClinicalTrials.gov |
| NCT00963001 | Effect of Food on the Pharmacokinetics of Oral Treprostinil | Phase1 | Hypertension, Pulmonary | Completed | 2009-09-01 | 2009-11-01 | ClinicalTrials.gov |
| NCT00969722 | A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CS… | Phase2 | Primary Refractory Neuroblastoma | Terminated | 2009-08-01 | — | ClinicalTrials.gov |
| NCT00887978 | Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hyperten… | Phase3 | Pulmonary Hypertension | Completed | 2009-06-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00775463 | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethano… | Phase2 | Systemic Sclerosis | Completed | 2009-05-01 | 2011-07-01 | ClinicalTrials.gov |
| NCT00848939 | Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis | Phase1 | Systemic Sclerosis | Completed | 2008-12-01 | 2010-04-01 | ClinicalTrials.gov |
| NCT00760916 | FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antago… | Phase3 | Pulmonary Hypertension | Withdrawn | 2008-12-01 | 2009-01-01 | ClinicalTrials.gov |
| NCT00741819 | Safety Evaluation of Inhaled Treprostinil Administration Following Transition F… | Phase4 | Pulmonary Arterial Hypertension | Completed | 2008-09-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00705133 | Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pul… | Phase2 | Pulmonary Arterial Hypertension | Completed | 2008-07-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT01884038 | Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant … | Phase2 | Liver Transplant | Withdrawn | 2008-06-01 | 2010-06-01 | ClinicalTrials.gov |
| NCT00643604 | Rapid Switch From Flolan to Remodulin in the Outpatient Clinic | Phase4 | Hypertension, Pulmonary | Terminated | 2008-03-01 | 2012-02-01 | ClinicalTrials.gov |
| NCT00651885 | Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Li… | Phase2 | Critical Limb Ischemia | Completed | 2008-03-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00458042 | Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Effic… | Phase4 | Hypertension, Pulmonary | Terminated | 2007-03-01 | 2007-11-01 | ClinicalTrials.gov |
| NCT00439946 | Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin… | Phase4 | Pulmonary Arterial Hypertension | Terminated | 2007-02-01 | 2011-03-01 | ClinicalTrials.gov |
| NCT01027949 | An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With… | Phase3 | Pulmonary Arterial Hypertension | Completed | 2007-01-16 | 2020-02-12 | ClinicalTrials.gov |
| NCT00325442 | FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagon… | Phase3 | Pulmonary Hypertension | Completed | 2006-10-01 | 2010-12-01 | ClinicalTrials.gov |
| NCT00325403 | FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Ar… | Phase3 | Pulmonary Hypertension | Completed | 2006-10-01 | 2011-04-01 | ClinicalTrials.gov |
| NCT00373360 | Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switch… | Phase4 | Pulmonary Hypertension | Completed | 2006-09-01 | 2008-01-01 | ClinicalTrials.gov |
| NCT00824603 | Impact of Continuing Medical Education (CME) Insulin Program | — | Diabetes | Completed | 2006-06-01 | 2009-08-01 | ClinicalTrials.gov |
| NCT03055221 | TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India Wit… | Phase4 | Pulmonary Arterial Hypertension | Completed | 2005-06-10 | 2014-02-25 | ClinicalTrials.gov |
| NCT00147199 | Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe… | Phase3 | Pulmonary Hypertension | Completed | 2005-06-01 | 2007-10-01 | ClinicalTrials.gov |
| NCT00494533 | Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hyp… | Phase4 | Pulmonary Arterial Hypertension | Terminated | 2005-03-01 | 2005-10-01 | ClinicalTrials.gov |
| NCT00164281 | Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in… | Phase4 | Tuberculosis | Completed | 2004-11-01 | 2011-05-01 | ClinicalTrials.gov |
| NCT00069511 | 12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C… | Phase2 | Hepatitis C | Unknown | 2003-07-01 | 2004-12-01 | ClinicalTrials.gov |
| NCT00067041 | Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein B… | Phase2 | Peripheral Vascular Disease | Terminated | 2003-03-01 | 2003-12-01 | ClinicalTrials.gov |
| NCT00060996 | Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Reva… | Phase3 | Critical Limb Ischemia | Terminated | 2003-02-01 | 2004-09-01 | ClinicalTrials.gov |
| NCT00058929 | A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arteri… | Phase4 | Pulmonary Arterial Hypertension | Completed | 2002-10-01 | 2005-08-01 | ClinicalTrials.gov |
| NCT00004497 | Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hyperten… | Phase3 | Pulmonary Hypertension | Completed | 1998-10-01 | 2000-09-01 | ClinicalTrials.gov |
| NCT02194582 | Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure | — | Focal Segmental Glomerulosclerosis | Active_Not_Recruiting | 1996-06-01 | 2035-01-01 | ClinicalTrials.gov |
| NCT01737242 | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | — | Prostate Cancer | Active_Not_Recruiting | 1993-01-01 | 2033-12-31 | ClinicalTrials.gov |
Total clinical trials: 358
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| BCI-TSCS | Other | Approved | Spinal Cord Injuries | RECRUITING | NCT06406855 |
| Placebo | Other | Phase PHASE1 | Maximum Tolerated Dose | ACTIVE_NOT_RECRUITING | NCT07762001 |
| AD-NP1 | Other | Phase PHASE1 | Maximum Tolerated Dose | ACTIVE_NOT_RECRUITING | NCT07762001 |
| Insulin Aspart Injection（NovoRapid®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07600944 |
| Insulin Aspart Injection（UBLIN®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07600944 |
| BoNT A | Other | Phase PHASE2 | Traumatic Brain Injury | RECRUITING | NCT06293300 |
| BathMat | Other | Approved | Acute Respiratory Distress Syndrome (ARDS) | COMPLETED | NCT06844617 |
| Counselling on healthy lifestyle intervention | Other | Phase PHASE4 | Cardiomyopathy | COMPLETED | NCT05371496 |
| Placebo | Other | Phase PHASE4 | Cardiomyopathy | COMPLETED | NCT05371496 |
| Semaglutide | Other | Phase PHASE4 | Cardiomyopathy | COMPLETED | NCT05371496 |
| Autologous Human Schwann Cell | Other | Phase PHASE1 | Peripheral Nerve Injury | RECRUITING | NCT05541250 |
| MICROFIT - personalised high intensity interval training exercise rehabilitation and dietary advice | Other | Approved | Microvascular Coronary Dysfunction | RECRUITING | NCT06681896 |
| Standard of care treatment + normal saline | Drug | Phase PHASE2 | Moderate Traumatic Brain Injury (TBI) | NOT_YET_RECRUITING | NCT07166393 |
| Valproic Acid (VPA) | Other | Phase PHASE2 | Moderate Traumatic Brain Injury (TBI) | NOT_YET_RECRUITING | NCT07166393 |
| NovoSorb® BTM | Other | Approved | Surgical Wound | RECRUITING | NCT06503406 |
| SupraSDRM® | Other | Approved | Surgical Wound | RECRUITING | NCT06503406 |
| TTRNA-DCs | Other | Phase PHASE2 | Medulloblastoma | COMPLETED | NCT01326104 |
| TTRNA-xALT | Other | Phase PHASE2 | Medulloblastoma | COMPLETED | NCT01326104 |
| Placebo | Other | Phase PHASE1 | Maximum Tolerated Dose | ACTIVE_NOT_RECRUITING | NCT07762001 |
| AD-NP1 | Other | Phase PHASE1 | Maximum Tolerated Dose | ACTIVE_NOT_RECRUITING | NCT07762001 |
| Intermittent CGM | Other | Preclinical | Type 1 Diabetes (T1D) | RECRUITING | NCT07742306 |
| Cementless total hip replacement | Other | Approved | Osteoarthritis, Hip | RECRUITING | NCT06162195 |
| The H1 Implant | Other | Approved | Osteoarthritis, Hip | RECRUITING | NCT06162195 |
| Standard meal | Other | Approved | School Attendance | COMPLETED | NCT06397989 |
| Ready-to-use school food | Other | Approved | School Attendance | COMPLETED | NCT06397989 |
| Control (placebo) | Other | Approved | Parkinson Disease (PD) | RECRUITING | NCT07115563 |
| Targeted Amino Acid Supplement | Other | Approved | Parkinson Disease (PD) | RECRUITING | NCT07115563 |
| Expressive Writing Workshop | Other | Approved | Hematologic Malignancy | ACTIVE_NOT_RECRUITING | NCT07413991 |
| Sham Device | Device | Approved | Bones Stress Injury | RECRUITING | NCT06609265 |
| Extracorporeal shockwave treatment (ESWT). | Drug | Approved | Bones Stress Injury | RECRUITING | NCT06609265 |
| Part2: Placebo | Other | Phase PHASE1 | Paroxysmal Nocturnal Hemoglobinuria, PNH | NOT_YET_RECRUITING | NCT07760467 |
| Part2: TUL321 | Other | Phase PHASE1 | Paroxysmal Nocturnal Hemoglobinuria, PNH | NOT_YET_RECRUITING | NCT07760467 |
| Part1: Placebo | Other | Phase PHASE1 | Paroxysmal Nocturnal Hemoglobinuria, PNH | NOT_YET_RECRUITING | NCT07760467 |
| Part1: TUL321 | Other | Phase PHASE1 | Paroxysmal Nocturnal Hemoglobinuria, PNH | NOT_YET_RECRUITING | NCT07760467 |
| Positron Emission Tomography | Other | Phase PHASE2 | Hepatocellular Carcinoma | COMPLETED | NCT04762888 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Hepatocellular Carcinoma | COMPLETED | NCT04762888 |
| Gallium Ga 68 Gozetotide | Other | Phase PHASE2 | Hepatocellular Carcinoma | COMPLETED | NCT04762888 |
| Computed Tomography | Other | Phase PHASE2 | Hepatocellular Carcinoma | COMPLETED | NCT04762888 |
| RETAINWORKS | Other | Approved | Disability | COMPLETED | NCT05167981 |
| Active Comparator | Other | Approved | Disability | COMPLETED | NCT05173350 |
| RETAIN KY | Other | Approved | Disability | COMPLETED | NCT05173350 |
| Small-quantity lipid-based nutrient supplement (SQ-LNS) | Other | Approved | Undernutrition | RECRUITING | NCT07451951 |
| Medium-quantity lipid-based nutrient supplement (MQ-LNS) | Other | Approved | Undernutrition | RECRUITING | NCT07451951 |
| Sham Device | Device | Approved | Bones Stress Injury | RECRUITING | NCT06609265 |
| Extracorporeal shockwave treatment (ESWT). | Drug | Approved | Bones Stress Injury | RECRUITING | NCT06609265 |
| Psilocybin | Other | Phase EARLY_PHASE1 | Amyotrophic Lateral Sclerosis | RECRUITING | NCT06656702 |
| Sterile saline | Other | Phase PHASE1 | Traumatic Brain Injury | RECRUITING | NCT06282965 |
| Angiotensin (1-7) | Other | Phase PHASE1 | Traumatic Brain Injury | RECRUITING | NCT06282965 |
| Recommended Phase II Dose | Other | Phase PHASE1 | Melanoma (Skin Cancer) | RECRUITING | NCT07718243 |
| Bexmarilimab 3mg/kg and nivolumab 1mg/kg | Other | Phase PHASE1 | Melanoma (Skin Cancer) | RECRUITING | NCT07718243 |
| Bexmarilimab 1mg/kg and nivolumab 1mg/kg | Other | Phase PHASE1 | Melanoma (Skin Cancer) | RECRUITING | NCT07718243 |
| Psilocybin (Usona Institute) | Other | Phase PHASE1 | Spinal Cord Injury | RECRUITING | NCT07251491 |
| Pancreatitis Quality of Life Instrument | Device | Phase PHASE2 | Chronic Pancreatitis | NOT_YET_RECRUITING | NCT07755813 |
| Brief Pain Inventory | Other | Phase PHASE2 | Chronic Pancreatitis | NOT_YET_RECRUITING | NCT07755813 |
| Comprehensive Pain Assessment Tool | Other | Phase PHASE2 | Chronic Pancreatitis | NOT_YET_RECRUITING | NCT07755813 |
| PROMIS-Global Health | Other | Phase PHASE2 | Chronic Pancreatitis | NOT_YET_RECRUITING | NCT07755813 |
| Placebo | Other | Phase PHASE2 | Chronic Pancreatitis | NOT_YET_RECRUITING | NCT07755813 |
| Pirfenidone 267 mg Oral Tablet | Other | Phase PHASE2 | Chronic Pancreatitis | NOT_YET_RECRUITING | NCT07755813 |
| Observation blinded group with the purpose of assessing the safety of a non-invasive decision support system for the identification and management of shock (the CRUISE system). | Other | Preclinical | Shock | NOT_YET_RECRUITING | NCT07637240 |
| Usual NHS Care | Other | Approved | Osteoarthritis (Knee) | RECRUITING | NCT07532785 |
| Good Boost+ | Other | Approved | Osteoarthritis (Knee) | RECRUITING | NCT07532785 |
| Usual Care | Other | Approved | Stroke | NOT_YET_RECRUITING | NCT07752563 |
| NeuroEyeCoach eye movement training | Other | Approved | Stroke | NOT_YET_RECRUITING | NCT07752563 |
| Deuterium oxide-labelled alfalfa sprouts | Other | Approved | Diet, Healthy | ACTIVE_NOT_RECRUITING | NCT04641026 |
| Alfalfa sprouts | Other | Approved | Diet, Healthy | ACTIVE_NOT_RECRUITING | NCT04641026 |
| Deuterium oxide-labelled broccoli sprouts | Other | Approved | Diet, Healthy | ACTIVE_NOT_RECRUITING | NCT04641026 |
| Broccoli sprouts | Other | Approved | Diet, Healthy | ACTIVE_NOT_RECRUITING | NCT04641026 |
| Early Achievements- Parent Coaching Intervention | Other | Approved | Autism Spectrum Disorder | COMPLETED | NCT05176808 |
| saline placebo | Other | Phase PHASE2 | Trauma | RECRUITING | NCT05958342 |
| Vasopressin | Other | Phase PHASE2 | Trauma | RECRUITING | NCT05958342 |
| Calcium Gluconate | Other | Phase PHASE2 | Trauma | RECRUITING | NCT05958342 |
| EVOLVE104 | Other | Phase PHASE1 | Bladder Cancer | RECRUITING | NCT07217171 |
| Deworming and vitamin A supplementation delivery | Other | Approved | Malaria | ACTIVE_NOT_RECRUITING | NCT06560853 |
| Comprehensive School Health Programme | Other | Approved | Malaria | ACTIVE_NOT_RECRUITING | NCT06560853 |
| Children and young people with life-limiting conditions, their parents/carers, and professionals across healthcare, education, and social care sectors. | Other | Preclinical | Complex Care | RECRUITING | NCT07102433 |
| Placebo | Other | Phase EARLY_PHASE1 | Recurrent Acute Pancreatitis | RECRUITING | NCT05771675 |
| Simvastatin | Other | Phase EARLY_PHASE1 | Recurrent Acute Pancreatitis | RECRUITING | NCT05771675 |
| Restless Bandit | Other | Approved | TBI (Traumatic Brain Injury) | RECRUITING | NCT07103200 |
| COGED | Other | Approved | TBI (Traumatic Brain Injury) | RECRUITING | NCT07103200 |
| Deworming and vitamin A supplementation delivery | Other | Approved | Malaria | ACTIVE_NOT_RECRUITING | NCT06560853 |
| Comprehensive School Health Programme | Other | Approved | Malaria | ACTIVE_NOT_RECRUITING | NCT06560853 |
| Placebo | Other | Phase PHASE3 | Acute Myeloid Leukemia, Adult | RECRUITING | NCT06652438 |
| Revumenib | Other | Phase PHASE3 | Acute Myeloid Leukemia, Adult | RECRUITING | NCT06652438 |
| Lenvatinib | Other | Phase PHASE2 | Locally Advanced Hepatocellular Carcinoma | RECRUITING | NCT05168163 |
| Cabozantinib | Other | Phase PHASE2 | Locally Advanced Hepatocellular Carcinoma | RECRUITING | NCT05168163 |
| Atezolizumab | Other | Phase PHASE2 | Locally Advanced Hepatocellular Carcinoma | RECRUITING | NCT05168163 |
| avutometinib capsule + defactinib tablet | Other | Phase PHASE2 | MPNST (Malignant Peripheral Nerve Sheath Tumor) | NOT_YET_RECRUITING | NCT07743554 |
| Neurofeedback | Other | Phase PHASE2 | PTSD | NOT_YET_RECRUITING | NCT07745569 |
| Psilocybin (drug) | Drug | Phase PHASE2 | PTSD | NOT_YET_RECRUITING | NCT07745569 |
| Transcranial Magnetic Stimulation | Other | Phase PHASE2 | PTSD | NOT_YET_RECRUITING | NCT07745569 |
| Closed-Loop DBS | Other | Approved | Chronic Pain | COMPLETED | NCT03029884 |
| Sham Stimulation | Other | Approved | Chronic Pain | COMPLETED | NCT03029884 |
| Open-Loop DBS | Other | Approved | Chronic Pain | COMPLETED | NCT03029884 |
| ECG-based AI Device - Results Not Returned to Investigator | Device | Approved | Pulmonary Hypertension | RECRUITING | NCT06911632 |
| Echocardiogram and Right Heart Catheterization | Other | Approved | Pulmonary Hypertension | RECRUITING | NCT06911632 |
| ECG-based AI Device - Results Returned to Investigator | Device | Approved | Pulmonary Hypertension | RECRUITING | NCT06911632 |
| Nivolumab | Other | Phase PHASE2 | BCLC Stage B Hepatocellular Carcinoma | TERMINATED | NCT05199285 |
| Ipilimumab | Other | Phase PHASE2 | BCLC Stage B Hepatocellular Carcinoma | TERMINATED | NCT05199285 |
| Placebo | Other | Phase PHASE3 | Acute Myeloid Leukemia, Adult | RECRUITING | NCT06652438 |
| Revumenib | Other | Phase PHASE3 | Acute Myeloid Leukemia, Adult | RECRUITING | NCT06652438 |
| Questionnaire Administration | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Positron Emission Tomography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Lumbar Puncture | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Leukapheresis | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Hydroxyurea | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Fludarabine Phosphate | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Echocardiography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Cyclophosphamide | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Computed Tomography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Chest Radiography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Biospecimen Collection | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Autologous Anti-CD83 CAR T-cells | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Qualitative interview | Other | Preclinical | Prostate Cancer | RECRUITING | NCT07741929 |
| Intermittent CGM | Other | Preclinical | Type 1 Diabetes (T1D) | RECRUITING | NCT07742306 |
| Questionnaire Administration | Other | Phase PHASE1 | Locally Advanced Clear Cell Renal Cell Carcinoma | RECRUITING | NCT06866262 |
| Nivolumab | Other | Phase PHASE1 | Locally Advanced Clear Cell Renal Cell Carcinoma | RECRUITING | NCT06866262 |
| Magnetic Resonance Imaging | Other | Phase PHASE1 | Locally Advanced Clear Cell Renal Cell Carcinoma | RECRUITING | NCT06866262 |
| Ipilimumab | Other | Phase PHASE1 | Locally Advanced Clear Cell Renal Cell Carcinoma | RECRUITING | NCT06866262 |
| Inulin | Other | Phase PHASE1 | Locally Advanced Clear Cell Renal Cell Carcinoma | RECRUITING | NCT06866262 |
| Computed Tomography | Other | Phase PHASE1 | Locally Advanced Clear Cell Renal Cell Carcinoma | RECRUITING | NCT06866262 |
| Biospecimen Collection | Other | Phase PHASE1 | Locally Advanced Clear Cell Renal Cell Carcinoma | RECRUITING | NCT06866262 |
| Biopsy | Other | Phase PHASE1 | Locally Advanced Clear Cell Renal Cell Carcinoma | RECRUITING | NCT06866262 |
| TGFBR2 KO CAR27/IL-15 NK cells | Other | Phase PHASE1 | Pancreatic Cancer | SUSPENDED | NCT07377526 |
| HCHS consumption | Other | Approved | Poor Sleep Quality | RECRUITING | NCT06430086 |
| Walnut consumption | Other | Approved | Poor Sleep Quality | RECRUITING | NCT06430086 |
| Telephone Outcome Assessment | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| EEG | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| Blood Draw | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| Clinical Visit | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| 3T Magnetic Resonance Imaging (MRI) | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| In-Person Outcome Assessment | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| UIC202305 and co-administration of UIC202304 and UIC202305 | Other | Phase PHASE1 | Healhty | COMPLETED | NCT07735052 |
| UIC202304 and co-administration of UIC202304 and UIC202305 | Other | Phase PHASE1 | Healhty | COMPLETED | NCT07735052 |
| Immunofluorescence Imaging | Other | Preclinical | Trauma Injury | COMPLETED | NCT04416412 |
| Placebo | Other | Phase PHASE3 | Acute Myeloid Leukemia, Adult | RECRUITING | NCT06652438 |
| Revumenib | Other | Phase PHASE3 | Acute Myeloid Leukemia, Adult | RECRUITING | NCT06652438 |
| Questionnaire Administration | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Positron Emission Tomography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Lumbar Puncture | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Leukapheresis | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Hydroxyurea | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Fludarabine Phosphate | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Echocardiography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Cyclophosphamide | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Computed Tomography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Chest Radiography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Biospecimen Collection | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Autologous Anti-CD83 CAR T-cells | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Data Collection | Other | Preclinical | Hereditary Transthyretin Amyloidosis With Polyneuropthy | ACTIVE_NOT_RECRUITING | NCT04850105 |
| Usual Care | Other | Approved | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT07047807 |
| PDAC-PATHWAYS | Other | Approved | PDAC - Pancreatic Ductal Adenocarcinoma | RECRUITING | NCT07047807 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Ketotifen Fumarate 5mg | Other | Phase PHASE3 | Elbow Fracture | COMPLETED | NCT03582176 |
| Ketotifen Fumarate 2mg | Other | Phase PHASE3 | Elbow Fracture | COMPLETED | NCT03582176 |
| Lactose Placebo | Other | Phase PHASE3 | Elbow Fracture | COMPLETED | NCT03582176 |
| Vedolizumab | Other | Phase PHASE4 | Ulcerative Colitis | NOT_YET_RECRUITING | NCT07665294 |
| Placebo | Other | Phase PHASE4 | Ulcerative Colitis | NOT_YET_RECRUITING | NCT07665294 |
| CurQD | Other | Phase PHASE4 | Ulcerative Colitis | NOT_YET_RECRUITING | NCT07665294 |
| Biospecimen Collection | Other | Phase PHASE2 | Lung Non-Small Cell Carcinoma | RECRUITING | NCT05242965 |
| Biopsy | Other | Phase PHASE2 | Lung Non-Small Cell Carcinoma | RECRUITING | NCT05242965 |
| Computed Tomography | Other | Phase PHASE2 | Lung Non-Small Cell Carcinoma | RECRUITING | NCT05242965 |
| Sargramostim | Other | Phase PHASE2 | Lung Non-Small Cell Carcinoma | RECRUITING | NCT05242965 |
| CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine | Other | Phase PHASE2 | Lung Non-Small Cell Carcinoma | RECRUITING | NCT05242965 |
| UIC202201 | Other | Phase PHASE1 | Gastro Esophageal Reflux Disorder | NOT_YET_RECRUITING | NCT07727629 |
| UI059 | Other | Phase PHASE1 | Gastro Esophageal Reflux Disorder | NOT_YET_RECRUITING | NCT07727629 |
| Semi-structured interview/focus group discussion | Other | Approved | Breast Cancer Female | COMPLETED | NCT06701019 |
| Moxifloxacin | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Rifapentine | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Ethambutol | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Pyrazinamide | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Rifampin | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Isoniazid | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Erenumab-Aooe Matching Placebo | Other | Phase PHASE2 | Schwannomatosis | RECRUITING | NCT05684692 |
| Siltuximab Matching Placebo | Other | Phase PHASE2 | Schwannomatosis | RECRUITING | NCT05684692 |
| Erenumab-Aooe | Other | Phase PHASE2 | Schwannomatosis | RECRUITING | NCT05684692 |
| Siltuximab | Other | Phase PHASE2 | Schwannomatosis | RECRUITING | NCT05684692 |
| Precision treatment | Drug | Approved | Smoking Cessation | RECRUITING | NCT07166120 |
| Usual care | Other | Approved | Smoking Cessation | RECRUITING | NCT07166120 |
| Usual Care | Other | Approved | Head and Neck Cancer | COMPLETED | NCT05570851 |
| Alcohol Cessation Text Messages | Other | Approved | Head and Neck Cancer | COMPLETED | NCT05570851 |
| Low-fat Mixed diet | Other | Approved | Heart Failure With Preserved Ejection Fraction | RECRUITING | NCT06081543 |
| Ketogenic diet | Other | Approved | Heart Failure With Preserved Ejection Fraction | RECRUITING | NCT06081543 |
| Supervised Resistance Exercise Programme | Other | Approved | Prostate Cancer | NOT_YET_RECRUITING | NCT07724080 |
| Blood Specimen Collection | Other | Phase PHASE1 | Solid Tumor | RECRUITING | NCT06942104 |
| Tumor Biopsy | Other | Phase PHASE1 | Solid Tumor | RECRUITING | NCT06942104 |
| Positron Emission Tomography (PET)/Computerized tomography (CT) | Other | Phase PHASE1 | Solid Tumor | RECRUITING | NCT06942104 |
| 18F-TRX | Other | Phase PHASE1 | Solid Tumor | RECRUITING | NCT06942104 |
| Metformin 1000 mg Oral Tablet | Other | Phase PHASE3 | Alzheimer's Disease (AD) | RECRUITING | NCT07724132 |
| Atomoxetine | Other | Phase PHASE3 | Alzheimer's Disease (AD) | RECRUITING | NCT07724132 |
| Placebo | Other | Phase PHASE3 | Alzheimer's Disease (AD) | RECRUITING | NCT07724132 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | NOT_YET_RECRUITING | NCT07721259 |
| Recombinant Granulocyte-Macrophage Colony-Stimulating Factor | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | NOT_YET_RECRUITING | NCT07721259 |
| CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | NOT_YET_RECRUITING | NCT07721259 |
| Placebo controlled group memory exercise training | Other | Approved | Traumatic Brain Injury | COMPLETED | NCT04056312 |
| Group Memory retraining exercises | Other | Approved | Traumatic Brain Injury | COMPLETED | NCT04056312 |
| Hydrogen Peroxide | Other | Phase EARLY_PHASE1 | Peri-Implantitis | COMPLETED | NCT05024760 |
| Chlorhexidine | Other | Phase EARLY_PHASE1 | Peri-Implantitis | COMPLETED | NCT05024760 |
| Rituximab and Hyaluronidase Human | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04626791 |
| Rituximab | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04626791 |
| Prednisone | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04626791 |
| Doxorubicin Hydrochloride | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04626791 |
| Cytarabine | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04626791 |
| Cyclophosphamide | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04626791 |
| Bortezomib | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04626791 |
| Acalabrutinib | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04626791 |
| Placebo | Other | Phase PHASE2 | Colorectal Adenoma | ACTIVE_NOT_RECRUITING | NCT03796884 |
| Linaclotide | Other | Phase PHASE2 | Colorectal Adenoma | ACTIVE_NOT_RECRUITING | NCT03796884 |
| pembrolizumab | Other | Phase PHASE1 | Malignant Pleural Disease | ACTIVE_NOT_RECRUITING | NCT02414269 |
| cyclophosphamide | Other | Phase PHASE1 | Malignant Pleural Disease | ACTIVE_NOT_RECRUITING | NCT02414269 |
| iCasp9M28z T cell infusions | Other | Phase PHASE1 | Malignant Pleural Disease | ACTIVE_NOT_RECRUITING | NCT02414269 |
| Control group | Other | Phase PHASE3 | Post Operative Surgical Site Infection | COMPLETED | NCT04597008 |
| Treatment group | Drug | Phase PHASE3 | Post Operative Surgical Site Infection | COMPLETED | NCT04597008 |
| PRIME/mhGAP | Other | Approved | Mental Disorders | COMPLETED | NCT02793271 |
| RESHAPE | Other | Approved | Mental Disorders | COMPLETED | NCT02793271 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Placebo | Other | Phase PHASE1 | Complicated Urinary Tract Infections(cUTI) | NOT_YET_RECRUITING | NCT07719257 |
| TUL108 | Other | Phase PHASE1 | Complicated Urinary Tract Infections(cUTI) | NOT_YET_RECRUITING | NCT07719257 |
| Expansile duraplasty | Other | Approved | Spinal Cord Injury, Acute | ENROLLING_BY_INVITATION | NCT07280351 |
| Pembrolizumab | Other | Phase PHASE2 | Anatomic Stage IV Breast Cancer AJCC v8 | RECRUITING | NCT04348747 |
| Anti-HER2/HER3 Dendritic Cell Vaccine | Other | Phase PHASE2 | Anatomic Stage IV Breast Cancer AJCC v8 | RECRUITING | NCT04348747 |
| Self-management booklet | Other | Approved | Depression | RECRUITING | NCT07064551 |
| Cognitive behavioural therapy-based stepped-care intervention | Drug | Approved | Depression | RECRUITING | NCT07064551 |
| Recommended Phase II Dose | Other | Phase PHASE1 | Melanoma (Skin Cancer) | NOT_YET_RECRUITING | NCT07718243 |
| Bexmarilimab 3mg/kg and nivolumab 1mg/kg | Other | Phase PHASE1 | Melanoma (Skin Cancer) | NOT_YET_RECRUITING | NCT07718243 |
| Bexmarilimab 1mg/kg and nivolumab 1mg/kg | Other | Phase PHASE1 | Melanoma (Skin Cancer) | NOT_YET_RECRUITING | NCT07718243 |
| GM-CSF | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Dinutuximab | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Irinotecan | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Temozolomide | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Universal Donor (UD) TGFβi NK Cells | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Insulin Icodec Injection | Other | Phase PHASE1 | Type 2 Diabetes Mellitus (T2DM) | NOT_YET_RECRUITING | NCT07630233 |
| Insulin Degludec Injection | Other | Phase PHASE1 | Type 2 Diabetes Mellitus (T2DM) | NOT_YET_RECRUITING | NCT07630233 |
| Placebo | Other | Phase PHASE1 | Type 2 Diabetes Mellitus (T2DM) | NOT_YET_RECRUITING | NCT07630233 |
| UBT38006 | Other | Phase PHASE1 | Type 2 Diabetes Mellitus (T2DM) | NOT_YET_RECRUITING | NCT07630233 |
| Moxifloxacin | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Rifapentine | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Ethambutol | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Pyrazinamide | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Rifampin | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Isoniazid | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Written Exposure Therapy | Drug | Approved | Post Traumatic Stress Disorder | NOT_YET_RECRUITING | NCT07715799 |
| Transcranial Direct Current Stimulator | Other | Approved | Post Traumatic Stress Disorder | NOT_YET_RECRUITING | NCT07715799 |
| Regorafenib | Other | Phase PHASE2 | Stage IB Hepatocellular Carcinoma AJCC v8 | ACTIVE_NOT_RECRUITING | NCT05194293 |
| Durvalumab | Other | Phase PHASE2 | Stage IB Hepatocellular Carcinoma AJCC v8 | ACTIVE_NOT_RECRUITING | NCT05194293 |
| Zymosan | Other | Phase EARLY_PHASE1 | Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer | COMPLETED | NCT04674306 |
| α-lactalbumin vaccine | Other | Phase EARLY_PHASE1 | Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer | COMPLETED | NCT04674306 |
| Elliptical exercise | Other | Phase PHASE1 | Adult | COMPLETED | NCT01175993 |
| Resting State MRI/Precision functional mapping | Other | Preclinical | Brain Tumor, Primary | RECRUITING | NCT06185686 |
| Cognitive testing | Other | Preclinical | Brain Tumor, Primary | RECRUITING | NCT06185686 |
| Testosterone enanthate | Other | Phase PHASE2 | Castration Resistant Metastatic Prostate Cancer | RECRUITING | NCT04363164 |
| Enzalutamide | Other | Phase PHASE2 | Castration Resistant Metastatic Prostate Cancer | RECRUITING | NCT04363164 |
| Testosterone cypionate | Other | Phase PHASE2 | Castration Resistant Metastatic Prostate Cancer | RECRUITING | NCT04363164 |
| TGFBR2 KO CAR27/IL-15 NK cells | Other | Phase PHASE1 | Pancreatic Cancer | RECRUITING | NCT07377526 |
| iSens | Other | Approved | Upper Extremity Amputee | RECRUITING | NCT04430218 |
| Fiber | Other | Approved | Age-Related Macular Degeneration | RECRUITING | NCT06237127 |
| Goji berry | Other | Approved | Age-Related Macular Degeneration | RECRUITING | NCT06237127 |
| AP1903 | Other | Phase PHASE1 | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT02792114 |
| Mesothelin-targeted T cells | Other | Phase PHASE1 | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT02792114 |
| Cyclophosphamide | Other | Phase PHASE1 | Breast Cancer | ACTIVE_NOT_RECRUITING | NCT02792114 |
| Usual care - Wait list control | Other | Approved | Health Promotion | RECRUITING | NCT07034352 |
| Health Impact 360 | Other | Approved | Health Promotion | RECRUITING | NCT07034352 |
| Mood Monitoring | Other | Approved | Depression | RECRUITING | NCT05456607 |
| Cognitive Behavioral Therapy for Depression | Drug | Approved | Depression | RECRUITING | NCT05456607 |
| Cognitive Behavioral Therapy for Insomnia | Drug | Approved | Depression | RECRUITING | NCT05456607 |
| Letters about NF1 Care | Other | Approved | Neurofibromatosis 1 | RECRUITING | NCT07233408 |
| Peer Navigator | Other | Approved | Neurofibromatosis 1 | RECRUITING | NCT07233408 |
| NF1 Educational Videos | Other | Approved | Neurofibromatosis 1 | RECRUITING | NCT07233408 |
| Standard of Care | Other | Approved | Pulmonary Arterial Hypertension PAH | ACTIVE_NOT_RECRUITING | NCT06477640 |
| Exercise | Other | Approved | Pulmonary Arterial Hypertension PAH | ACTIVE_NOT_RECRUITING | NCT06477640 |
| accelerated intermittent theta burst stimulation | Other | Phase PHASE2 | Long COVID | RECRUITING | NCT06940609 |
| Allevyn Foam (Standard of Care Control) | Other | Approved | Wound Closure | NOT_YET_RECRUITING | NCT07695688 |
| Microlyte DualGuard | Other | Approved | Wound Closure | NOT_YET_RECRUITING | NCT07695688 |
| Placebo | Other | Phase EARLY_PHASE1 | Ovarian Cancer | RECRUITING | NCT05080946 |
| Aspirin 325mg | Other | Phase EARLY_PHASE1 | Ovarian Cancer | RECRUITING | NCT05080946 |
| Nivolumab | Other | Phase PHASE2 | Breast Cancer | RECRUITING | NCT07694986 |
| Trastuzumab | Other | Phase PHASE2 | Breast Cancer | RECRUITING | NCT07694986 |
| cDC1 Vaccine | Other | Phase PHASE2 | Breast Cancer | RECRUITING | NCT07694986 |
| Fermented chickpea | Other | Approved | Fermented Food | NOT_YET_RECRUITING | NCT06134076 |
| Unfermented chickpea | Other | Approved | Fermented Food | NOT_YET_RECRUITING | NCT06134076 |
| Placebo | Other | Phase PHASE4 | Diarrhea | ENROLLING_BY_INVITATION | NCT07300462 |
| Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules) | Other | Phase PHASE4 | Diarrhea | ENROLLING_BY_INVITATION | NCT07300462 |
| OPM- Magnetoencephalography | Other | Approved | Autoimmune Encephalitis (AE) | ACTIVE_NOT_RECRUITING | NCT07689682 |
| Control Arm | Other | Approved | Fasting | NOT_YET_RECRUITING | NCT07691736 |
| Fibre Arm | Other | Approved | Fasting | NOT_YET_RECRUITING | NCT07691736 |
| OPM- Magnetoencephalography | Other | Approved | Autoimmune Encephalitis (AE) | ACTIVE_NOT_RECRUITING | NCT07689682 |
| Elliptical exercise | Other | Phase PHASE1 | Adult | COMPLETED | NCT01175993 |
| Administration of UIC202006 | Other | Phase PHASE1 | Dyslipidemia | COMPLETED | NCT07691268 |
| Administration of UI111 | Other | Phase PHASE1 | Dyslipidemia | COMPLETED | NCT07691268 |
| Virtual Reality Immersive Relaxation | Other | Approved | Bariatric Surgery Candidate | ACTIVE_NOT_RECRUITING | NCT04754165 |
| Walking | Other | Approved | Spinal Cord Injury | ACTIVE_NOT_RECRUITING | NCT02632422 |
| dSHAM | Other | Approved | Spinal Cord Injury | ACTIVE_NOT_RECRUITING | NCT02632422 |
| Daily acute intermittent hypoxia (dAIH) | Other | Approved | Spinal Cord Injury | ACTIVE_NOT_RECRUITING | NCT02632422 |
| Wafermine™ (ketamine sublingual wafer) | Other | Phase PHASE1 | Healthy Adult Participants | NOT_YET_RECRUITING | NCT07691372 |
| Lactobacillus Rhamnosus GG | Other | Phase EARLY_PHASE1 | Spinal Cord Injury | NOT_YET_RECRUITING | NCT07643974 |
| Gentamicin | Other | Phase EARLY_PHASE1 | Spinal Cord Injury | NOT_YET_RECRUITING | NCT07643974 |
| Sham Virtual Reality Experience | Other | Approved | Total Knee Arthroplasty | COMPLETED | NCT04748549 |
| Immersive Audio Experience | Other | Approved | Total Knee Arthroplasty | COMPLETED | NCT04748549 |
| Virtual Reality Immersive Relaxation | Other | Approved | Total Knee Arthroplasty | COMPLETED | NCT04748549 |
| cyclophosphamide | Other | Phase PHASE1 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT01140373 |
| engineered autologous T cells | Other | Phase PHASE1 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT01140373 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Investigational Product 1 + Investigational Product 2 | Other | Phase PHASE1 | Hypertension | RECRUITING | NCT07682948 |
| Investigational Product 2 | Other | Phase PHASE1 | Hypertension | RECRUITING | NCT07682948 |
| Investigational Product 1 | Other | Phase PHASE1 | Hypertension | RECRUITING | NCT07682948 |
| Nerve Transfer | Other | Approved | Spinal Cord Injury | COMPLETED | NCT01714349 |
| Standard care | Other | Phase PHASE3 | Burn Injury | NOT_YET_RECRUITING | NCT07212998 |
| Plasma | Other | Phase PHASE3 | Burn Injury | NOT_YET_RECRUITING | NCT07212998 |
| EVOLVE104 | Other | Phase PHASE1 | Bladder Cancer | RECRUITING | NCT07217171 |
| Acupuncture | Other | Approved | Spinal Cord Injuries | COMPLETED | NCT03197675 |
| Fiber | Other | Approved | Age-Related Macular Degeneration | RECRUITING | NCT06237127 |
| Goji berry | Other | Approved | Age-Related Macular Degeneration | RECRUITING | NCT06237127 |
| i-STAT Alinity TBI test | Other | Preclinical | TBI (Traumatic Brain Injury) | RECRUITING | NCT07373509 |
| Placebo (two doses) | Other | Phase PHASE1 | Osteoarthritis | TERMINATED | NCT04589611 |
| amobarbital/Gel-One (two doses) | Other | Phase PHASE1 | Osteoarthritis | TERMINATED | NCT04589611 |
| Placebo (single dose) | Other | Phase PHASE1 | Osteoarthritis | TERMINATED | NCT04589611 |
| amobarbital/Gel-One (one dose) | Other | Phase PHASE1 | Osteoarthritis | TERMINATED | NCT04589611 |
| Placebo | Other | Phase PHASE3 | Pulmonary Hypertension | TERMINATED | NCT04084678 |
| Ralinepag | Other | Phase PHASE3 | Pulmonary Hypertension | TERMINATED | NCT04084678 |
| 0.9% Sodium Chloride (Placebo) | Other | Phase PHASE2 | Acute Pancreatitis | RECRUITING | NCT03684278 |
| Infusion of 10 mg/kg Infliximab | Other | Phase PHASE2 | Acute Pancreatitis | RECRUITING | NCT03684278 |
| Infusion of 5 mg/kg Infliximab | Other | Phase PHASE2 | Acute Pancreatitis | RECRUITING | NCT03684278 |
| Counselling on healthy lifestyle intervention | Other | Phase PHASE4 | Cardiomyopathy | ENROLLING_BY_INVITATION | NCT05371496 |
| Placebo | Other | Phase PHASE4 | Cardiomyopathy | ENROLLING_BY_INVITATION | NCT05371496 |
| Semaglutide | Other | Phase PHASE4 | Cardiomyopathy | ENROLLING_BY_INVITATION | NCT05371496 |
| EVOLVE104 | Other | Phase PHASE1 | Bladder Cancer | RECRUITING | NCT07217171 |
| Elliptical exercise | Other | Phase PHASE1 | Adult | COMPLETED | NCT01175993 |
| Survey | Other | Approved | Pancreatic Cancer | ACTIVE_NOT_RECRUITING | NCT06001268 |
| Nutrition Counseling | Other | Approved | Pancreatic Cancer | ACTIVE_NOT_RECRUITING | NCT06001268 |
| Fitbit Data Collection | Other | Approved | Pancreatic Cancer | ACTIVE_NOT_RECRUITING | NCT06001268 |
| FLT PET/CT | Other | Phase PHASE1 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT04989946 |
| Fianlimab | Other | Phase PHASE1 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT04989946 |
| Cemiplimab | Other | Phase PHASE1 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT04989946 |
| Nivolumab | Other | Phase PHASE1 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT04989946 |
| pTVG-AR | Other | Phase PHASE1 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT04989946 |
| Degarelix | Other | Phase PHASE1 | Prostate Cancer | ACTIVE_NOT_RECRUITING | NCT04989946 |
| ECG-based AI Device - Results Not Returned to Investigator | Device | Approved | Pulmonary Hypertension | RECRUITING | NCT06911632 |
| Echocardiogram and Right Heart Catheterization | Other | Approved | Pulmonary Hypertension | RECRUITING | NCT06911632 |
| ECG-based AI Device - Results Returned to Investigator | Device | Approved | Pulmonary Hypertension | RECRUITING | NCT06911632 |
| BathMat | Other | Approved | Acute Respiratory Distress Syndrome (ARDS) | ACTIVE_NOT_RECRUITING | NCT06844617 |
| IDEO brace | Other | Approved | Leg Injuries | COMPLETED | NCT02158884 |
| Placebo | Other | Phase PHASE4 | Post-traumatic Stress Disorder | TERMINATED | NCT01555554 |
| Propranolol Hydrochloride | Other | Phase PHASE4 | Post-traumatic Stress Disorder | TERMINATED | NCT01555554 |
| Placebo | Other | Phase PHASE1 | Multiple Sclerosis (MS) | RECRUITING | NCT05359653 |
| Clemastine Fumarate | Other | Phase PHASE1 | Multiple Sclerosis (MS) | RECRUITING | NCT05359653 |
| Control (placebo) | Other | Approved | Parkinson Disease (PD) | RECRUITING | NCT07115563 |
| Targeted Amino Acid Supplement | Other | Approved | Parkinson Disease (PD) | RECRUITING | NCT07115563 |
| Sham | Other | Phase PHASE4 | Sleep Apnea | RECRUITING | NCT02922894 |
| Placebo | Other | Phase PHASE4 | Sleep Apnea | RECRUITING | NCT02922894 |
| Trazodone | Other | Phase PHASE4 | Sleep Apnea | RECRUITING | NCT02922894 |
| Supplemental oxygen | Other | Phase PHASE4 | Sleep Apnea | RECRUITING | NCT02922894 |
| Acute episodic hypoxia | Other | Phase PHASE4 | Sleep Apnea | RECRUITING | NCT02922894 |
| Transthoracic echocardiogram | Other | Preclinical | Pulmonary Hypertension | ACTIVE_NOT_RECRUITING | NCT06038149 |
| Adiposity and Iron Requirements in Pregnancy (ADIPREG) | Other | Approved | Iron Deficiency Anemia of Pregnancy | RECRUITING | NCT06425796 |
| Treatment as Usual | Drug | Approved | Suicidal | ACTIVE_NOT_RECRUITING | NCT05795764 |
| Crisis Response Planning | Other | Approved | Suicidal | ACTIVE_NOT_RECRUITING | NCT05795764 |
| Alectinib - Study | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Alectinib - Usual | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Ketone Supplementation | Other | Approved | Prostate Cancer | RECRUITING | NCT06826924 |
| Fasting | Other | Approved | Prostate Cancer | RECRUITING | NCT06826924 |
| Food Kit | Other | Approved | Pregnant Women With Singleton Pregnancies | RECRUITING | NCT07659821 |
| Usual Care Rehabilitation | Other | Approved | Concussion, Mild | RECRUITING | NCT06819904 |
| Acceptance and Commitment Therapy Integrated Rehabilitation (ACT) | Drug | Approved | Concussion, Mild | RECRUITING | NCT06819904 |
| Elliptical exercise | Other | Phase PHASE1 | Adult | COMPLETED | NCT01175993 |
| Sargramostim | Other | Phase PHASE2 | Bilateral Breast Carcinoma | ACTIVE_NOT_RECRUITING | NCT03012100 |
| Placebo Administration | Other | Phase PHASE2 | Bilateral Breast Carcinoma | ACTIVE_NOT_RECRUITING | NCT03012100 |
| Multi-epitope Folate Receptor Alpha Peptide Vaccine | Other | Phase PHASE2 | Bilateral Breast Carcinoma | ACTIVE_NOT_RECRUITING | NCT03012100 |
| Laboratory Biomarker Analysis | Other | Phase PHASE2 | Bilateral Breast Carcinoma | ACTIVE_NOT_RECRUITING | NCT03012100 |
| Cyclophosphamide | Other | Phase PHASE2 | Bilateral Breast Carcinoma | ACTIVE_NOT_RECRUITING | NCT03012100 |
| Prolonged exposure | Other | Approved | PTSD | RECRUITING | NCT06285708 |
| Biospecimen Collection | Other | Phase PHASE2 | Recurrent Fallopian Tube Carcinoma | COMPLETED | NCT04387227 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Recurrent Fallopian Tube Carcinoma | COMPLETED | NCT04387227 |
| Computed Tomography | Other | Phase PHASE2 | Recurrent Fallopian Tube Carcinoma | COMPLETED | NCT04387227 |
| Pembrolizumab | Other | Phase PHASE2 | Recurrent Fallopian Tube Carcinoma | COMPLETED | NCT04387227 |
| Carboplatin | Other | Phase PHASE2 | Recurrent Fallopian Tube Carcinoma | COMPLETED | NCT04387227 |
| Placebo | Other | Phase PHASE3 | Chikungunya Virus | RECRUITING | NCT07467707 |
| CHIKV VLP vaccine | Other | Phase PHASE3 | Chikungunya Virus | RECRUITING | NCT07467707 |
| MRI | Other | Approved | Brain Tumor | RECRUITING | NCT05658731 |
| Neurocognitive Testing | Other | Approved | Brain Tumor | RECRUITING | NCT05658731 |
| substructure informed planning | Other | Approved | Brain Tumor | RECRUITING | NCT05658731 |
| Non-invasive ventilation | Other | Phase PHASE2 | Amyotrophic Lateral Sclerosis (ALS) | RECRUITING | NCT07071935 |
| Inspiratory muscle training | Other | Approved | Respiratory Muscle Training | RECRUITING | NCT07637331 |
| Diet Guidance for Usual Diet | Other | Approved | Crohn's Disease, Active | NOT_YET_RECRUITING | NCT07671872 |
| Catered Anti-Inflammatory Diet | Other | Approved | Crohn's Disease, Active | NOT_YET_RECRUITING | NCT07671872 |
| Telemedicine-based Cognitive Behavioral Therapy (TCBT) | Drug | Approved | Posttraumatic Headache | RECRUITING | NCT05620719 |
| Treatment as Usual | Drug | Approved | Posttraumatic Headache | RECRUITING | NCT05620719 |
| Cognitive Behavioral Therapy for Posttraumatic Headache | Drug | Approved | Posttraumatic Headache | RECRUITING | NCT05620719 |
| Routine Care | Other | Approved | Pregnancy | ACTIVE_NOT_RECRUITING | NCT06087133 |
| StEP:Prenatal | Other | Approved | Pregnancy | ACTIVE_NOT_RECRUITING | NCT06087133 |
| Pembrolizumab | Other | Phase PHASE1 | Advanced Cancer | ACTIVE_NOT_RECRUITING | NCT05082259 |
| ASTX660 | Other | Phase PHASE1 | Advanced Cancer | ACTIVE_NOT_RECRUITING | NCT05082259 |
| Placebo | Other | Phase PHASE2 | Colorectal Adenoma | ACTIVE_NOT_RECRUITING | NCT03796884 |
| Linaclotide | Other | Phase PHASE2 | Colorectal Adenoma | ACTIVE_NOT_RECRUITING | NCT03796884 |
| BloodTrackR - Home Blood Collection Platform | Other | Preclinical | Rheumatoid Arthritis (RA) | RECRUITING | NCT07660029 |
| Vedolizumab | Other | Phase PHASE4 | Ulcerative Colitis | NOT_YET_RECRUITING | NCT07665294 |
| Placebo | Other | Phase PHASE4 | Ulcerative Colitis | NOT_YET_RECRUITING | NCT07665294 |
| CurQD | Other | Phase PHASE4 | Ulcerative Colitis | NOT_YET_RECRUITING | NCT07665294 |
| Elliptical exercise | Other | Phase PHASE1 | Adult | COMPLETED | NCT01175993 |
| Uneven terrain locomotor training | Other | Approved | Amputation | RECRUITING | NCT06419920 |
| Flat terrain locomotor training | Other | Approved | Amputation | RECRUITING | NCT06419920 |
| Patient educational material | Other | Approved | Testicular Cancer | NOT_YET_RECRUITING | NCT06702592 |
| Virtual support | Other | Approved | Testicular Cancer | NOT_YET_RECRUITING | NCT06702592 |
| UBT251 Injection Placebo 6.0 mg | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07659574 |
| UBT251 Injection Placebo 4.0 mg | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07659574 |
| UBT251 Injection Placebo 2.0 mg | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07659574 |
| UBT251 Injection 6.0 mg | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07659574 |
| UBT251 Injection 4.0 mg | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07659574 |
| UBT251 Injection 2.0 mg | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07659574 |
| BloodTrackR - Home Blood Collection Platform | Other | Preclinical | Rheumatoid Arthritis (RA) | NOT_YET_RECRUITING | NCT07660029 |
| Methotrexate | Other | Preclinical | Psoriatic Arthritis | COMPLETED | NCT03531073 |
| Positron Emission Tomography (PET)/Computerized tomography (CT) | Other | Phase PHASE2 | Thyroid Cancer | RECRUITING | NCT06961084 |
| Iodine-124 | Other | Phase PHASE2 | Thyroid Cancer | RECRUITING | NCT06961084 |
| Questionnaire Administration | Other | Phase EARLY_PHASE1 | Advanced Ovarian Carcinoma | RECRUITING | NCT07144826 |
| Probiotic | Other | Phase EARLY_PHASE1 | Advanced Ovarian Carcinoma | RECRUITING | NCT07144826 |
| Placebo Administration | Other | Phase EARLY_PHASE1 | Advanced Ovarian Carcinoma | RECRUITING | NCT07144826 |
| Biospecimen Collection | Other | Phase EARLY_PHASE1 | Advanced Ovarian Carcinoma | RECRUITING | NCT07144826 |
| Elliptical exercise | Other | Phase PHASE1 | Adult | COMPLETED | NCT01175993 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Direct-Acting Oral Anticoagulants (used as per local standard practice) | Other | Phase PHASE3 | Traumatic Intracranial Haemorrhage | RECRUITING | NCT06322953 |
| rF1V-1018 | Other | Phase PHASE2 | Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis | RECRUITING | NCT07207408 |
| Olaparib | Other | Phase PHASE2 | Pancreatic Cancer | RECRUITING | NCT05093231 |
| Pembrolizumab | Other | Phase PHASE2 | Pancreatic Cancer | RECRUITING | NCT05093231 |
| Semaglutide Injection | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07653477 |
| UBT251 Injection 6.0 mg group | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07653477 |
| UBT251 Injection 4.0 mg group | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07653477 |
| UBT251 Injection 2.0 mg group | Other | Phase PHASE3 | Type 2 Diabetes | NOT_YET_RECRUITING | NCT07653477 |
| Surgery/Occupational Therapy | Drug | Preclinical | Tetraplegia | ACTIVE_NOT_RECRUITING | NCT04023591 |
| Alectinib - Study | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Alectinib - Usual | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Pre-recorded music | Other | Approved | Renal Failure | COMPLETED | NCT06478524 |
| Live music | Other | Approved | Renal Failure | COMPLETED | NCT06478524 |
| Placebo | Other | Phase PHASE3 | PAH | COMPLETED | NCT03626688 |
| Ralinepag | Other | Phase PHASE3 | PAH | COMPLETED | NCT03626688 |
| stem cell reinfusion | Other | Phase PHASE3 | Germ Cell Tumor | ACTIVE_NOT_RECRUITING | NCT02375204 |
| etoposide phosphate | Other | Phase PHASE3 | Germ Cell Tumor | ACTIVE_NOT_RECRUITING | NCT02375204 |
| carboplatin | Other | Phase PHASE3 | Germ Cell Tumor | ACTIVE_NOT_RECRUITING | NCT02375204 |
| G-CSF | Other | Phase PHASE3 | Germ Cell Tumor | ACTIVE_NOT_RECRUITING | NCT02375204 |
| pegylated G-CSF | Other | Phase PHASE3 | Germ Cell Tumor | ACTIVE_NOT_RECRUITING | NCT02375204 |
| cisplatin | Other | Phase PHASE3 | Germ Cell Tumor | ACTIVE_NOT_RECRUITING | NCT02375204 |
| ifosfamide | Other | Phase PHASE3 | Germ Cell Tumor | ACTIVE_NOT_RECRUITING | NCT02375204 |
| paclitaxel | Other | Phase PHASE3 | Germ Cell Tumor | ACTIVE_NOT_RECRUITING | NCT02375204 |
| Non-invasive ventilation | Other | Phase PHASE2 | Amyotrophic Lateral Sclerosis (ALS) | RECRUITING | NCT07071935 |
| Elliptical exercise | Other | Phase PHASE1 | Adult | COMPLETED | NCT01175993 |
| UBT251 Injection Placebo 6.0 mg | Other | Phase PHASE3 | Obesity & Overweight | NOT_YET_RECRUITING | NCT07648225 |
| UBT251 Injection Placebo 4.0 mg | Other | Phase PHASE3 | Obesity & Overweight | NOT_YET_RECRUITING | NCT07648225 |
| UBT251 Injection 6.0 mg | Other | Phase PHASE3 | Obesity & Overweight | NOT_YET_RECRUITING | NCT07648225 |
| UBT251 Injection 4.0 mg | Other | Phase PHASE3 | Obesity & Overweight | NOT_YET_RECRUITING | NCT07648225 |
| THOR3 training + sham PBMT | Other | Approved | Photobiomodulation Therapy | COMPLETED | NCT06380179 |
| THOR3 training + Photobiomodulation Therapy (PBMT) | Drug | Approved | Photobiomodulation Therapy | COMPLETED | NCT06380179 |
| Information | Other | Approved | Posttraumatic Stress Disorder (PTSD) | RECRUITING | NCT07220681 |
| Positive affect | Other | Approved | Posttraumatic Stress Disorder (PTSD) | RECRUITING | NCT07220681 |
| Wellness | Other | Approved | Posttraumatic Stress Disorder (PTSD) | RECRUITING | NCT07220681 |
| Yoga and meditation | Other | Approved | Posttraumatic Stress Disorder (PTSD) | RECRUITING | NCT07220681 |
| Standard meal | Other | Approved | School Attendance | ACTIVE_NOT_RECRUITING | NCT06397989 |
| Ready-to-use school food | Other | Approved | School Attendance | ACTIVE_NOT_RECRUITING | NCT06397989 |
| Lactobacillus Rhamnosus GG | Other | Phase EARLY_PHASE1 | Spinal Cord Injury | NOT_YET_RECRUITING | NCT07643974 |
| Gentamicin | Other | Phase EARLY_PHASE1 | Spinal Cord Injury | NOT_YET_RECRUITING | NCT07643974 |
| Neural recordings and stimulation | Other | Approved | Parkinson Disease | ACTIVE_NOT_RECRUITING | NCT05933681 |
| Program 2 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Program 1 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Stress and Symptom Management Program 2 | Other | Approved | Neurofibromatoses | COMPLETED | NCT03873610 |
| Stress and Symptom Management Program 1 | Other | Approved | Neurofibromatoses | COMPLETED | NCT03873610 |
| Standard of Care Intravenous (IV) antibiotics | Other | Phase PHASE3 | Infections | RECRUITING | NCT05699174 |
| Standard of Care PO (oral) antibiotics | Other | Phase PHASE3 | Infections | RECRUITING | NCT05699174 |
| intraosseous antibiotic delivery | Other | Approved | Osseointegration Infection | NOT_YET_RECRUITING | NCT07621094 |
| GM-CSF | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Dinutuximab | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Irinotecan | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Temozolomide | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Universal Donor (UD) TGFβi NK Cells | Other | Phase PHASE2 | Neuroblastoma | RECRUITING | NCT06450041 |
| Prospective study assessments | Other | Preclinical | Pulmonary Hypertension Due to Lung Diseases and Hypoxia | RECRUITING | NCT06388421 |
| Questionnaire Administration | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Positron Emission Tomography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Lumbar Puncture | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Leukapheresis | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Hydroxyurea | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Fludarabine Phosphate | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Echocardiography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Cyclophosphamide | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Computed Tomography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Chest Radiography | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Biospecimen Collection | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| Autologous Anti-CD83 CAR T-cells | Other | Phase PHASE1 | Recurrent Acute Myeloid Leukemia | RECRUITING | NCT06871410 |
| COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | Covid19 | ACTIVE_NOT_RECRUITING | NCT03305341 |
| Observation blinded group with the purpose of assessing the safety of a non-invasive decision support system for the identification and management of shock (the CRUISE system). | Other | Preclinical | Shock | NOT_YET_RECRUITING | NCT07637240 |
| Inspiratory muscle training | Other | Approved | Respiratory Muscle Training | RECRUITING | NCT07637331 |
| Standard reporting procedure (no AI assistance) | Procedure | Approved | Thoracic Diseases | RECRUITING | NCT07634861 |
| AI-generated report for chest CT | Other | Approved | Thoracic Diseases | RECRUITING | NCT07634861 |
| Placebo Tablets | Other | Phase PHASE4 | Eczema | NOT_YET_RECRUITING | NCT07447063 |
| Sodium chloride tablets | Other | Phase PHASE4 | Eczema | NOT_YET_RECRUITING | NCT07447063 |
| Filler Product | Other | Phase PHASE2 | Wounds and Injuries | RECRUITING | NCT01964859 |
| autologous skin fibroblasts | Other | Phase PHASE2 | Wounds and Injuries | RECRUITING | NCT01964859 |
| Standard meal | Other | Approved | School Attendance | ACTIVE_NOT_RECRUITING | NCT06397989 |
| Ready-to-use school food | Other | Approved | School Attendance | ACTIVE_NOT_RECRUITING | NCT06397989 |
| Placebo | Other | Phase PHASE2 | Amputation | RECRUITING | NCT03947450 |
| Autologous Skin Fibroblasts | Other | Phase PHASE2 | Amputation | RECRUITING | NCT03947450 |
| Bupivacaine (Hyperbaric 0.5%) | Other | Phase PHASE4 | Cervical Incompetence in Pregnancy as Antepartum Condition | COMPLETED | NCT04394533 |
| Prilocaine (Hyperbaric 2%) | Other | Phase PHASE4 | Cervical Incompetence in Pregnancy as Antepartum Condition | COMPLETED | NCT04394533 |
| DC Device use in community and home | Device | Approved | Amputation | RECRUITING | NCT07075042 |
| PRC Device use in community and home | Device | Approved | Amputation | RECRUITING | NCT07075042 |
| Training with DC | Other | Approved | Amputation | RECRUITING | NCT07075042 |
| Training with PRC | Other | Approved | Amputation | RECRUITING | NCT07075042 |
| Sympathetic Nerve Activity | Other | Preclinical | Brain Blood Flow | ACTIVE_NOT_RECRUITING | NCT04586049 |
| Transcranial Doppler Ultrasound | Other | Preclinical | Brain Blood Flow | ACTIVE_NOT_RECRUITING | NCT04586049 |
| MRI | Other | Preclinical | Brain Blood Flow | ACTIVE_NOT_RECRUITING | NCT04586049 |
| PPR Seri Alam Fasa 2 (Intervention Group) | Other | Approved | Sarcopenia | NOT_YET_RECRUITING | NCT07325760 |
| Insulin Degludec Injection | Other | Phase PHASE1 | Type 2 Diabetes Mellitus (T2DM) | NOT_YET_RECRUITING | NCT07630233 |
| Placebo | Other | Phase PHASE1 | Type 2 Diabetes Mellitus (T2DM) | NOT_YET_RECRUITING | NCT07630233 |
| UBT38006 | Other | Phase PHASE1 | Type 2 Diabetes Mellitus (T2DM) | NOT_YET_RECRUITING | NCT07630233 |
| CTCA | Other | Approved | Coronary Heart Disease | RECRUITING | NCT07165678 |
| Sleep Education (SE) | Other | Approved | Gulf War Illness | COMPLETED | NCT05137743 |
| Apnea and Insomnia Relief (AIR) | Other | Approved | Gulf War Illness | COMPLETED | NCT05137743 |
| Arnovie101 Infusion Intravenous | Other | Phase EARLY_PHASE1 | Systemic Lupus Erythematosus | RECRUITING | NCT07629596 |
| Food is Medicine | Other | Approved | Food Insecurity | NOT_YET_RECRUITING | NCT07376044 |
| Placebo | Other | Phase PHASE2 | Neurofibromatosis 1 | COMPLETED | NCT04481048 |
| N-Acetyl cysteine | Other | Phase PHASE2 | Neurofibromatosis 1 | COMPLETED | NCT04481048 |
| PTAIR Computer Vision Model Assessment | Other | Preclinical | Thyroid Diseases | NOT_YET_RECRUITING | NCT07628543 |
| Supervised Cough Training | Other | Approved | Spinal Cord Injuries (SCI) | NOT_YET_RECRUITING | NCT07626931 |
| Respiratory Muscle Stimulator | Other | Approved | Spinal Cord Injuries (SCI) | NOT_YET_RECRUITING | NCT07626931 |
| THe usual care intervention is a first contact physiotherapy service. | Drug | Approved | Musculoskeletal Disorders | RECRUITING | NCT07112508 |
| PRISM dashboard is a data report | Other | Approved | Musculoskeletal Disorders | RECRUITING | NCT07112508 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Bronchoscopy with Bronchoalveolar Lavage (BAL) | Other | Preclinical | Copd | RECRUITING | NCT04722835 |
| tDCS | Other | Approved | Autism Spectrum Disorder | RECRUITING | NCT04446442 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Placebo | Other | Phase PHASE1 | Tendinopathy | RECRUITING | NCT06100822 |
| Metformin | Other | Phase PHASE1 | Tendinopathy | RECRUITING | NCT06100822 |
| Asynchronous exercise (Control) | Other | Approved | Spinal Cord Injury | RECRUITING | NCT07022808 |
| Synchronous Group exercise | Other | Approved | Spinal Cord Injury | RECRUITING | NCT07022808 |
| Beanstalk mobile app | Other | Approved | Obesity, Childhood | COMPLETED | NCT06520072 |
| Children Eating Well (CHEW) mobile app | Other | Approved | Obesity, Childhood | COMPLETED | NCT06520072 |
| PREPARE Optimized Clinical Assessment | Other | Preclinical | Musculoskeletal Injuries | RECRUITING | NCT05111925 |
| PREPARE Initial Clinical Assessment - Post-Injury (up to three iterations) | Other | Preclinical | Musculoskeletal Injuries | RECRUITING | NCT05111925 |
| PREPARE Initial Clinical Assessment - Pre-Injury (one iteration) | Other | Preclinical | Musculoskeletal Injuries | RECRUITING | NCT05111925 |
| PREPARE Initial Clinical Assessment - Pilot (two iterations) | Other | Preclinical | Musculoskeletal Injuries | RECRUITING | NCT05111925 |
| virtual reality exercise | Other | Approved | Spinal Cord Injuries (SCI) | RECRUITING | NCT06690372 |
| saline placebo | Other | Phase PHASE2 | Trauma | RECRUITING | NCT05958342 |
| Vasopressin | Other | Phase PHASE2 | Trauma | RECRUITING | NCT05958342 |
| Calcium Gluconate | Other | Phase PHASE2 | Trauma | RECRUITING | NCT05958342 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | RECRUITING | NCT07605962 |
| EVOLVE104 | Other | Phase PHASE1 | Bladder Cancer | RECRUITING | NCT07217171 |
| Sham breath synchronized abdominal FES | Other | Approved | Respiration, Artificial | COMPLETED | NCT05759013 |
| Breath synchronized abdominal FES | Other | Approved | Respiration, Artificial | COMPLETED | NCT05759013 |
| intraosseous antibiotic delivery | Other | Approved | Osseointegration Infection | NOT_YET_RECRUITING | NCT07621094 |
| Small-quantity lipid-based nutrient supplement (SQ-LNS) | Other | Approved | Undernutrition | RECRUITING | NCT07451951 |
| Medium-quantity lipid-based nutrient supplement (MQ-LNS) | Other | Approved | Undernutrition | RECRUITING | NCT07451951 |
| Moxifloxacin | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Rifapentine | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Ethambutol | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Pyrazinamide | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Rifampin | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Isoniazid | Other | Phase PHASE3 | Tuberculosis | RECRUITING | NCT06253715 |
| Verasonics research scanner | Other | Approved | Breast Tumor | RECRUITING | NCT04692818 |
| GE Logiq E10 clinical ultrasound scanner | Other | Approved | Breast Tumor | RECRUITING | NCT04692818 |
| Education | Other | Approved | Lumbar Spine Degenerative Changes | RECRUITING | NCT07406997 |
| Empowered Relief | Other | Approved | Lumbar Spine Degenerative Changes | RECRUITING | NCT07406997 |
| Human Insulin Injection（NOVOLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| Human Insulin Injection（USLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| Alectinib - Study | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Alectinib - Usual | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Elliptical exercise | Other | Phase PHASE1 | Adult | COMPLETED | NCT01175993 |
| Man Therapy | Drug | Approved | Mild Traumatic Brain Injury (mTBI) | NOT_YET_RECRUITING | NCT07604701 |
| Alectinib - Study | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Alectinib - Usual | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Telephone Outcome Assessment | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| EEG | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| Blood Draw | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| Clinical Visit | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| 3T Magnetic Resonance Imaging (MRI) | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| In-Person Outcome Assessment | Other | Preclinical | Traumatic Brain Injury | ACTIVE_NOT_RECRUITING | NCT05823766 |
| Elliptical exercise | Other | Phase PHASE1 | Adult | COMPLETED | NCT01175993 |
| Quality of Life Questionnaires | Other | Phase PHASE4 | Coronary Artery Disease | ACTIVE_NOT_RECRUITING | NCT03417388 |
| Lifestyle Counseling | Other | Phase PHASE4 | Coronary Artery Disease | ACTIVE_NOT_RECRUITING | NCT03417388 |
| Aspirin 81 enteric coated tablet daily | Other | Phase PHASE4 | Coronary Artery Disease | ACTIVE_NOT_RECRUITING | NCT03417388 |
| ACE-I (lisinopril) or ARB (losartan) | Other | Phase PHASE4 | Coronary Artery Disease | ACTIVE_NOT_RECRUITING | NCT03417388 |
| High dose potent statin | Other | Phase PHASE4 | Coronary Artery Disease | ACTIVE_NOT_RECRUITING | NCT03417388 |
| a small molecular multi-target kinase inhibitor | Other | Phase PHASE1 | Advance Solid Tumors | NOT_YET_RECRUITING | NCT07612488 |
| Midazolam | Other | Phase PHASE2 | Multiple Sclerosis Fatigue | ACTIVE_NOT_RECRUITING | NCT05378100 |
| Ketamine | Other | Phase PHASE2 | Multiple Sclerosis Fatigue | ACTIVE_NOT_RECRUITING | NCT05378100 |
| Right heart catheterization (RHC) | Other | Preclinical | Interstitial Lung Disease | COMPLETED | NCT05776225 |
| CEA protein antigen plus BCG Vaccine Mix for percutaneous use | Other | Phase PHASE1 | Rectal Cancer | ACTIVE_NOT_RECRUITING | NCT02403505 |
| Act With Her (simple) | Other | Approved | Adolescent Behavior | ACTIVE_NOT_RECRUITING | NCT03890237 |
| Act With Her + Asset Transfer | Other | Approved | Adolescent Behavior | ACTIVE_NOT_RECRUITING | NCT03890237 |
| Act With Her | Other | Approved | Adolescent Behavior | ACTIVE_NOT_RECRUITING | NCT03890237 |
| Her Spaces | Other | Approved | Adolescent Behavior | ACTIVE_NOT_RECRUITING | NCT03890237 |
| Bili-ruler | Other | Preclinical | Jaundice, Neonatal | COMPLETED | NCT06687746 |
| sham aVNS | Other | Approved | Spinal Cord Injuries | COMPLETED | NCT06588608 |
| auricular nerve stimulation (aVNS) | Other | Approved | Spinal Cord Injuries | COMPLETED | NCT06588608 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| RETAIN Program | Other | Approved | Injuries Related Work | COMPLETED | NCT05216016 |
| Inhaled treprostinil solution | Other | Phase PHASE3 | Pulmonary Hypertension | TERMINATED | NCT03794583 |
| Human Insulin Injection（NOVOLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| Human Insulin Injection（USLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| GGTA1 KO Thymokidney | Other | Phase PHASE1 | ESRD (End-Stage Renal Disease) | RECRUITING | NCT07224763 |
| Isoniazid | Other | Phase PHASE4 | Tuberculosis | COMPLETED | NCT00164281 |
| Standard interventional management of low back pain | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| SPRINT Peripheral Nerve Stimulation (PNS) System | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| Sirolimus | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| Selumetinib | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| RETAIN Program | Other | Approved | Injuries Related Work | COMPLETED | NCT05216016 |
| Inhaled treprostinil solution | Other | Phase PHASE3 | Pulmonary Hypertension | TERMINATED | NCT03794583 |
| Human Insulin Injection（NOVOLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| Human Insulin Injection（USLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| GGTA1 KO Thymokidney | Other | Phase PHASE1 | ESRD (End-Stage Renal Disease) | RECRUITING | NCT07224763 |
| Isoniazid | Other | Phase PHASE4 | Tuberculosis | COMPLETED | NCT00164281 |
| Standard interventional management of low back pain | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| SPRINT Peripheral Nerve Stimulation (PNS) System | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| Sirolimus | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| Selumetinib | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| RETAIN Program | Other | Approved | Injuries Related Work | COMPLETED | NCT05216016 |
| Inhaled treprostinil solution | Other | Phase PHASE3 | Pulmonary Hypertension | TERMINATED | NCT03794583 |
| Human Insulin Injection（NOVOLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| Human Insulin Injection（USLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| GGTA1 KO Thymokidney | Other | Phase PHASE1 | ESRD (End-Stage Renal Disease) | RECRUITING | NCT07224763 |
| Isoniazid | Other | Phase PHASE4 | Tuberculosis | COMPLETED | NCT00164281 |
| Standard interventional management of low back pain | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| SPRINT Peripheral Nerve Stimulation (PNS) System | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| Sirolimus | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| Selumetinib | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| RETAIN Program | Other | Approved | Injuries Related Work | COMPLETED | NCT05216016 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Inhaled treprostinil solution | Other | Phase PHASE3 | Pulmonary Hypertension | TERMINATED | NCT03794583 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Human Insulin Injection（NOVOLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| Human Insulin Injection（USLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| GGTA1 KO Thymokidney | Other | Phase PHASE1 | ESRD (End-Stage Renal Disease) | RECRUITING | NCT07224763 |
| Isoniazid | Other | Phase PHASE4 | Tuberculosis | COMPLETED | NCT00164281 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Standard interventional management of low back pain | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| SPRINT Peripheral Nerve Stimulation (PNS) System | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Sirolimus | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| Selumetinib | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| RETAIN Program | Other | Approved | Injuries Related Work | COMPLETED | NCT05216016 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Inhaled treprostinil solution | Other | Phase PHASE3 | Pulmonary Hypertension | TERMINATED | NCT03794583 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Human Insulin Injection（NOVOLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| Human Insulin Injection（USLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| GGTA1 KO Thymokidney | Other | Phase PHASE1 | ESRD (End-Stage Renal Disease) | RECRUITING | NCT07224763 |
| Isoniazid | Other | Phase PHASE4 | Tuberculosis | COMPLETED | NCT00164281 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Standard interventional management of low back pain | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| SPRINT Peripheral Nerve Stimulation (PNS) System | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Sirolimus | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| Selumetinib | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| RETAIN Program | Other | Approved | Injuries Related Work | COMPLETED | NCT05216016 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Inhaled treprostinil solution | Other | Phase PHASE3 | Pulmonary Hypertension | TERMINATED | NCT03794583 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Human Insulin Injection（NOVOLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| Human Insulin Injection（USLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| GGTA1 KO Thymokidney | Other | Phase PHASE1 | ESRD (End-Stage Renal Disease) | RECRUITING | NCT07224763 |
| Isoniazid | Other | Phase PHASE4 | Tuberculosis | COMPLETED | NCT00164281 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Standard interventional management of low back pain | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| SPRINT Peripheral Nerve Stimulation (PNS) System | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Sirolimus | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| Selumetinib | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| RETAIN Program | Other | Approved | Injuries Related Work | COMPLETED | NCT05216016 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Inhaled treprostinil solution | Other | Phase PHASE3 | Pulmonary Hypertension | TERMINATED | NCT03794583 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Human Insulin Injection（NOVOLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| Human Insulin Injection（USLIN®R） | Other | Phase PHASE1 | Pharmacokinetics and Pharmacodynamics | COMPLETED | NCT07608692 |
| GGTA1 KO Thymokidney | Other | Phase PHASE1 | ESRD (End-Stage Renal Disease) | RECRUITING | NCT07224763 |
| Isoniazid | Other | Phase PHASE4 | Tuberculosis | COMPLETED | NCT00164281 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Standard interventional management of low back pain | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| SPRINT Peripheral Nerve Stimulation (PNS) System | Other | Approved | Low Back Pain | COMPLETED | NCT04246281 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Sirolimus | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| Selumetinib | Other | Phase PHASE2 | Malignant Peripheral Nerve Sheath Tumors | COMPLETED | NCT03433183 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| NeuroLife EMG-FES Sleeve System | Other | Approved | Cervical Spinal Cord Injury | COMPLETED | NCT06087445 |
| Massed Prolonged Exposure (PE) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Placebo | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| 3,4-Methylenedioxymethamphetamine (MDMA) | Other | Phase PHASE2 | Post Traumatic Stress Disorder | RECRUITING | NCT07288151 |
| Medical Image Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Data Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Tissue Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Blood Sample Collection | Other | Preclinical | Pancreatic Cancer | RECRUITING | NCT05687188 |
| Vancomycin and Tobramycin | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Standard of care | Other | Phase PHASE3 | Post Operative Surgical Site Infection | RECRUITING | NCT04678154 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| Placebo | Other | Phase PHASE3 | Progressive Pulmonary Fibrosis | RECRUITING | NCT05943535 |
| UI-102 | Other | Phase PHASE1 | Advanced Cancer | NOT_YET_RECRUITING | NCT07605962 |
| Definitive fixation with a locked IM nail or plate | Other | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Surgery with an external ring fixator | Procedure | Phase PHASE3 | Severe Open Fractures of the Tibia (Shin) Bone | COMPLETED | NCT01494519 |
| Experimental arm | Other | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Standard treatment: Control arm | Drug | Phase PHASE3 | Cervical Carcinoma | RECRUITING | NCT05581121 |
| Brief Pain Reprocessing Therapy (BPRT) | Drug | Approved | Chronic Lower Back Pain (CLBP) | RECRUITING | NCT06771713 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Insulin Aspart Injection（NovoRapid®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Insulin Aspart Injection（UBLIN®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Alectinib - Study | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Alectinib - Usual | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Program 2 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Program 1 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Man Therapy | Drug | Approved | Problematic Anger | NOT_YET_RECRUITING | NCT07604701 |
| Brief Pain Reprocessing Therapy (BPRT) | Drug | Approved | Chronic Lower Back Pain (CLBP) | RECRUITING | NCT06771713 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Insulin Aspart Injection（NovoRapid®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Insulin Aspart Injection（UBLIN®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Alectinib - Study | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Alectinib - Usual | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Program 2 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Program 1 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Man Therapy | Drug | Approved | Problematic Anger | NOT_YET_RECRUITING | NCT07604701 |
| Brief Pain Reprocessing Therapy (BPRT) | Drug | Approved | Chronic Lower Back Pain (CLBP) | RECRUITING | NCT06771713 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Insulin Aspart Injection（NovoRapid®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Insulin Aspart Injection（UBLIN®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Alectinib - Study | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Alectinib - Usual | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Program 2 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Program 1 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Man Therapy | Drug | Approved | Problematic Anger | NOT_YET_RECRUITING | NCT07604701 |
| Brief Pain Reprocessing Therapy (BPRT) | Drug | Approved | Chronic Lower Back Pain (CLBP) | RECRUITING | NCT06771713 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Insulin Aspart Injection（NovoRapid®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Insulin Aspart Injection（UBLIN®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Alectinib - Study | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Alectinib - Usual | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Program 2 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Program 1 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Man Therapy | Drug | Approved | Problematic Anger | NOT_YET_RECRUITING | NCT07604701 |
| Brief Pain Reprocessing Therapy (BPRT) | Drug | Approved | Chronic Lower Back Pain (CLBP) | RECRUITING | NCT06771713 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Insulin Aspart Injection（NovoRapid®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Insulin Aspart Injection（UBLIN®） | Other | Approved | Pharmacokinetics and Pharmacodynamics | RECRUITING | NCT07600944 |
| Alectinib - Study | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Alectinib - Usual | Other | Phase PHASE2 | ALK-Positive Non-Small Cell Lung Cancer (NSCLC) | ACTIVE_NOT_RECRUITING | NCT05987956 |
| Program 2 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Program 1 | Other | Approved | Mild Traumatic Brain Injury | RECRUITING | NCT07436754 |
| Man Therapy | Drug | Approved | Problematic Anger | NOT_YET_RECRUITING | NCT07604701 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| 9vHPV Vaccine plus BCG Vaccine Mix for percutaneous use | Other | Phase EARLY_PHASE1 | HPV Infection | ACTIVE_NOT_RECRUITING | NCT06959563 |
| Physical Therapy | Drug | Approved | Burn Injury | ACTIVE_NOT_RECRUITING | NCT04368117 |
| Cool B70 Treatment Coil - Active Only | Drug | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Sham (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool D-B80 AP Coil - Active (dm-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil- Sham (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Cool B70 AP Coil - Active (dl-PFC) | Other | Approved | Post Traumatic Stress Disorder | RECRUITING | NCT06544408 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Albumin Human | Other | Approved | Burn Injury | COMPLETED | NCT04356859 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| UIC201604 or UIC201801 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| UI022 or UI023 and co-administration of matching placebo | Other | Phase PHASE3 | Peripheral Arterial Disease | COMPLETED | NCT07600385 |
| Venetoclax 100 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 50 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Venetoclax 10 MG Oral Tablet [Venclexta] | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Ibrutinib 560 mg | Other | Phase PHASE2 | Mantle Cell Lymphoma | ACTIVE_NOT_RECRUITING | NCT04802590 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Intramuscular electrodes | Other | Approved | Amputation | RECRUITING | NCT06275282 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Biospecimen Collection | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Biopsy Procedure | Procedure | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Ultrasound Imaging | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Carboplatin | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Docetaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Pertuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Trastuzumab | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Paclitaxel | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine | Other | Phase PHASE2 | Anatomic Stage I Breast Cancer AJCC v8 | RECRUITING | NCT04329065 |
| Teriparatide | Other | Phase PHASE4 | Osteoporosis | COMPLETED | NCT01293292 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Autologous Engineered Urethral Construct | Other | Phase PHASE1 | Urologic Diseases | RECRUITING | NCT03258658 |
| Tobramycin Injection | Other | Phase PHASE3 | Wound Infection | ACTIVE_NOT_RECRUITING | NCT04964947 |
| Olaparib | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Computed Tomography | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Biospecimen Collection | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Mobilization and Tactile Stimulation (MTS) | Other | Approved | Stroke | RECRUITING | NCT07589855 |
| Diagnostic Ultrasound System | Other | Preclinical | Pregnancy | NOT_YET_RECRUITING | NCT07590063 |
| Platelet RNA-based assay | Other | Preclinical | Lung Cancer | NOT_YET_RECRUITING | NCT07460440 |
| Placebo | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Propranolol Hydrochloride | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Tobramycin Injection | Other | Phase PHASE3 | Wound Infection | ACTIVE_NOT_RECRUITING | NCT04964947 |
| Olaparib | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Computed Tomography | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Biospecimen Collection | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Mobilization and Tactile Stimulation (MTS) | Other | Approved | Stroke | RECRUITING | NCT07589855 |
| Diagnostic Ultrasound System | Other | Preclinical | Pregnancy | NOT_YET_RECRUITING | NCT07590063 |
| Platelet RNA-based assay | Other | Preclinical | Lung Cancer | NOT_YET_RECRUITING | NCT07460440 |
| Placebo | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Propranolol Hydrochloride | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Tobramycin Injection | Other | Phase PHASE3 | Wound Infection | ACTIVE_NOT_RECRUITING | NCT04964947 |
| Olaparib | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Computed Tomography | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Biospecimen Collection | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Mobilization and Tactile Stimulation (MTS) | Other | Approved | Stroke | RECRUITING | NCT07589855 |
| Diagnostic Ultrasound System | Other | Preclinical | Pregnancy | NOT_YET_RECRUITING | NCT07590063 |
| Platelet RNA-based assay | Other | Preclinical | Lung Cancer | NOT_YET_RECRUITING | NCT07460440 |
| Placebo | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Propranolol Hydrochloride | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Tobramycin Injection | Other | Phase PHASE3 | Wound Infection | ACTIVE_NOT_RECRUITING | NCT04964947 |
| Olaparib | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Computed Tomography | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Biospecimen Collection | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Mobilization and Tactile Stimulation (MTS) | Other | Approved | Stroke | RECRUITING | NCT07589855 |
| Diagnostic Ultrasound System | Other | Preclinical | Pregnancy | NOT_YET_RECRUITING | NCT07590063 |
| Platelet RNA-based assay | Other | Preclinical | Lung Cancer | NOT_YET_RECRUITING | NCT07460440 |
| Placebo | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Propranolol Hydrochloride | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Tobramycin Injection | Other | Phase PHASE3 | Wound Infection | ACTIVE_NOT_RECRUITING | NCT04964947 |
| Olaparib | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Computed Tomography | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Biospecimen Collection | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Mobilization and Tactile Stimulation (MTS) | Other | Approved | Stroke | RECRUITING | NCT07589855 |
| Diagnostic Ultrasound System | Other | Preclinical | Pregnancy | NOT_YET_RECRUITING | NCT07590063 |
| Platelet RNA-based assay | Other | Preclinical | Lung Cancer | NOT_YET_RECRUITING | NCT07460440 |
| Placebo | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Propranolol Hydrochloride | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Tobramycin Injection | Other | Phase PHASE3 | Wound Infection | ACTIVE_NOT_RECRUITING | NCT04964947 |
| Olaparib | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Computed Tomography | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Biospecimen Collection | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Standard of Care (SOC) Multimodal Analgesia | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Ketorolac Injection | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Mobilization and Tactile Stimulation (MTS) | Other | Approved | Stroke | RECRUITING | NCT07589855 |
| Diagnostic Ultrasound System | Other | Preclinical | Pregnancy | NOT_YET_RECRUITING | NCT07590063 |
| Platelet RNA-based assay | Other | Preclinical | Lung Cancer | NOT_YET_RECRUITING | NCT07460440 |
| Placebo | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Propranolol Hydrochloride | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Tobramycin Injection | Other | Phase PHASE3 | Wound Infection | ACTIVE_NOT_RECRUITING | NCT04964947 |
| Olaparib | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Computed Tomography | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Biospecimen Collection | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Standard of Care (SOC) Multimodal Analgesia | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Ketorolac Injection | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Mobilization and Tactile Stimulation (MTS) | Other | Approved | Stroke | RECRUITING | NCT07589855 |
| Diagnostic Ultrasound System | Other | Preclinical | Pregnancy | NOT_YET_RECRUITING | NCT07590063 |
| Platelet RNA-based assay | Other | Preclinical | Lung Cancer | NOT_YET_RECRUITING | NCT07460440 |
| Placebo | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Propranolol Hydrochloride | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Tobramycin Injection | Other | Phase PHASE3 | Wound Infection | ACTIVE_NOT_RECRUITING | NCT04964947 |
| Olaparib | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Magnetic Resonance Imaging | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Computed Tomography | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Biospecimen Collection | Other | Phase PHASE2 | Bile Duct Adenocarcinoma | ACTIVE_NOT_RECRUITING | NCT04042831 |
| Standard of Care (SOC) Multimodal Analgesia | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Ketorolac Injection | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Mobilization and Tactile Stimulation (MTS) | Other | Approved | Stroke | RECRUITING | NCT07589855 |
| Diagnostic Ultrasound System | Other | Preclinical | Pregnancy | NOT_YET_RECRUITING | NCT07590063 |
| Platelet RNA-based assay | Other | Preclinical | Lung Cancer | NOT_YET_RECRUITING | NCT07460440 |
| Placebo | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Propranolol Hydrochloride | Other | Phase PHASE1 | Postoperative Chylothorax | SUSPENDED | NCT06833320 |
| Treprostinil Ultrasonic Nebulizer | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Inhaled Treprostinil | Other | Phase PHASE3 | Idiopathic Pulmonary Fibrosis | ENROLLING_BY_INVITATION | NCT04905693 |
| Standard of Care (SOC) Multimodal Analgesia | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Ketorolac Injection | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Standard of Care (SOC) Multimodal Analgesia | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Ketorolac Injection | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Standard of Care (SOC) Multimodal Analgesia | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Ketorolac Injection | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| umbilical cord-derived mesenchymal stromal cells (UC-MSCs) | Other | Phase PHASE2 | Ischemic Heart Disease | RECRUITING | NCT06145035 |
| Volunteer-led physical activity | Other | Approved | Hospital-associated Deconditioning | RECRUITING | NCT06017934 |
| Standard of Care (SOC) Multimodal Analgesia | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Ketorolac Injection | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Biologic or targeted synthetic DMARD (b/tsDMARD) | Other | Preclinical | Psoriasis Arthritis | NOT_YET_RECRUITING | NCT07417995 |
| umbilical cord-derived mesenchymal stromal cells (UC-MSCs) | Other | Phase PHASE2 | Ischemic Heart Disease | RECRUITING | NCT06145035 |
| Volunteer-led physical activity | Other | Approved | Hospital-associated Deconditioning | RECRUITING | NCT06017934 |
| Standard of Care (SOC) Multimodal Analgesia | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Ketorolac Injection | Other | Phase PHASE4 | Orthopaedic Trauma | RECRUITING | NCT06201676 |
| Biologic or targeted synthetic DMARD (b/tsDMARD) | Other | Preclinical | Psoriasis Arthritis | NOT_YET_RECRUITING | NCT07417995 |
| umbilical cord-derived mesenchymal stromal cells (UC-MSCs) | Other | Phase PHASE2 | Ischemic Heart Disease | RECRUITING | NCT06145035 |
| Biologic or targeted synthetic DMARD (b/tsDMARD) | Other | Preclinical | Psoriasis Arthritis | NOT_YET_RECRUITING | NCT07417995 |
| Volunteer-led physical activity | Other | Approved | Hospital-associated Deconditioning | RECRUITING | NCT06017934 |
| umbilical cord-derived mesenchymal stromal cells (UC-MSCs) | Other | Phase PHASE2 | Ischemic Heart Disease | RECRUITING | NCT06145035 |
| Biologic or targeted synthetic DMARD (b/tsDMARD) | Other | Preclinical | Psoriasis Arthritis | NOT_YET_RECRUITING | NCT07417995 |
| Volunteer-led physical activity | Other | Approved | Hospital-associated Deconditioning | RECRUITING | NCT06017934 |
| umbilical cord-derived mesenchymal stromal cells (UC-MSCs) | Other | Phase PHASE2 | Ischemic Heart Disease | RECRUITING | NCT06145035 |
| Biologic or targeted synthetic DMARD (b/tsDMARD) | Other | Preclinical | Psoriasis Arthritis | NOT_YET_RECRUITING | NCT07417995 |
| Volunteer-led physical activity | Other | Approved | Hospital-associated Deconditioning | RECRUITING | NCT06017934 |
| umbilical cord-derived mesenchymal stromal cells (UC-MSCs) | Other | Phase PHASE2 | Ischemic Heart Disease | RECRUITING | NCT06145035 |
| Biologic or targeted synthetic DMARD (b/tsDMARD) | Other | Preclinical | Psoriasis Arthritis | NOT_YET_RECRUITING | NCT07417995 |
| CCT3833 | Other | Phase PHASE1 | Melanoma | COMPLETED | NCT02437227 |
| Volunteer-led physical activity | Other | Approved | Hospital-associated Deconditioning | RECRUITING | NCT06017934 |
| CCT3833 | Other | Phase PHASE1 | Melanoma | COMPLETED | NCT02437227 |
| CCT3833 | Other | Phase PHASE1 | Melanoma | COMPLETED | NCT02437227 |
| CCT3833 | Other | Phase PHASE1 | Melanoma | COMPLETED | NCT02437227 |
| CCT3833 | Other | Phase PHASE1 | Melanoma | COMPLETED | NCT02437227 |
Total products: 1397